Publications from OUS - Dept. of Microbiology, Virology research group (Kaarbø)

475 publications found

Publications 2019

  1. Hesstvedt L, Gaustad P, Müller F, Torp Andersen C, Brunborg C, Mylvaganam H, Leiva RA, Berdal JE, Egil Ranheim T, Johnsen BO, Falch BM, Grimnes G, Skogen V, Haarr E, Sandmo Lyngøy A, Wik Larssen K, Hannula R, Åsheim Hansen B, Nordøy I, Norwegian Fungal Network (2019)
    The impact of age on risk assessment, therapeutic practice and outcome in candidemia
    Infect Dis (Lond), 51 (6), 425-434
    DOI 10.1080/23744235.2019.1595709, PubMed 31010380
  2. Huik K, Soodla P, Pauskar M, Owen SM, Luo W, Murphy G, Jogeda EL, Kallas E, Rajasaar H, Avi R, Masciotra S, Lutsar I, Del Amo J, Meyer L, Bucher HC, Chene G, Hamouda O, Pillay D, Prins M, Rosinska M, Sabin C, Touloumi G, Porter K, Olson A, Cartier A et al. (2019)
    The concordance of the limiting antigen and the Bio-Rad avidity assays in persons from Estonia infected mainly with HIV-1 CRF06_cpx
    PLoS One, 14 (5), e0217048
  3. Paraskevis D, Beloukas A, Stasinos K, Pantazis N, de Mendoza C, Bannert N, Meyer L, Zangerle R, Gill J, Prins M, d'Arminio Montforte A, Kran AB, Porter K, Touloumi G, CASCADE collaboration of EuroCoord (2019)
    HIV-1 molecular transmission clusters in nine European countries and Canada: association with demographic and clinical factors
    BMC Med, 17 (1), 4
    DOI 10.1186/s12916-018-1241-1, PubMed 30616632
  4. Quist-Paulsen E, Kran AB, Lindland ES, Ellefsen K, Sandvik L, Dunlop O, Ormaasen V (2019)
    To what extent can clinical characteristics be used to distinguish encephalitis from encephalopathy of other causes? Results from a prospective observational study
    BMC Infect Dis, 19 (1), 80
    DOI 10.1186/s12879-018-3570-2, PubMed 30669985

Publications 2018

  1. Barlinn R, Dudman SG, Trogstad L, Gibory M, Muller F, Magnus P, Rollag H (2018)
    Maternal and congenital cytomegalovirus infections in a population-based pregnancy cohort study
    APMIS, 126 (12), 899-906
    DOI 10.1111/apm.12899, PubMed 30378168
  2. Knudsen PK, Gammelsrud KW, Alfsnes K, Steinbakk M, Abrahamsen TG, Müller F, Bohlin J (2018)
    Transfer of a bla CTX-M-1-carrying plasmid between different Escherichia coli strains within the human gut explored by whole genome sequencing analyses
    Sci Rep, 8 (1), 280
    DOI 10.1038/s41598-017-18659-2, PubMed 29321570
  3. Nordheim E, Olafsson Storrø M, Natvik AK, Birkeland Kro G, Midtvedt K, Varberg Reisaeter A, Hagness M, Fevang B, Pettersen FO (2018)
    Donor-derived strongyloidiasis after organ transplantation in Norway
    Transpl Infect Dis, 21 (1), e13008
    DOI 10.1111/tid.13008, PubMed 30295406
  4. Nordøy I, Hesstvedt L, Torp Andersen C, Mylvaganam H, Kols NI, Falch BM, Tofteland S, Müller F, Denning DW (2018)
    An Estimate of the Burden of Fungal Disease in Norway
    J Fungi (Basel), 4 (1)
    DOI 10.3390/jof4010029, PubMed 29466284
  5. Olson A, Bannert N, Sönnerborg A, de Mendoza C, Price M, Zangerle R, Chaix ML, Prins M, Kran AB, Gill J, Paraskevis D, Porter K, for CASCADE Collaboration in EuroCoord (2018)
    Temporal trends of transmitted HIV drug resistance in a multinational seroconversion cohort
    AIDS, 32 (2), 161-169
    DOI 10.1097/QAD.0000000000001689, PubMed 29112061
  6. Quist-Paulsen E, Aukrust P, Kran AB, Dunlop O, Ormaasen V, Stiksrud B, Midttun Ø, Ueland T, Ueland PM, Mollnes TE, Dyrhol-Riise AM (2018)
    High neopterin and IP-10 levels in cerebrospinal fluid are associated with neurotoxic tryptophan metabolites in acute central nervous system infections
    J Neuroinflammation, 15 (1), 327
    DOI 10.1186/s12974-018-1366-3, PubMed 30470234
  7. Winje BA, White R, Syre H, Skutlaberg DH, Oftung F, Mengshoel AT, Blix HS, Brantsæter AB, Holter EK, Handal N, Simonsen GS, Afset JE, Bakken Kran AM (2018)
    Stratification by interferon-γ release assay level predicts risk of incident TB
    73 (7), 652-661
    DOI 10.1136/thoraxjnl-2017-211147, PubMed 29622693

Publications 2017

  1. Barlinn R, Rollag H, Trogstad L, Vainio K, Basset C, Magnus P, Dudman SG (2017)
    High incidence of maternal parvovirus B19 infection in a large unselected population-based pregnancy cohort in Norway
    J Clin Virol, 94, 57-62
    DOI 10.1016/j.jcv.2017.07.010, PubMed 28759773
  2. Hole K, Størset E, Olastuen A, Haslemo T, Kro GB, Midtvedt K, Åsberg A, Molden E (2017)
    Recovery of CYP3A Phenotype after Kidney Transplantation
    45 (12), 1260-1265
    DOI 10.1124/dmd.117.078030, PubMed 28928137
  3. Knudsen PK, Brandtzaeg P, Høiby EA, Bohlin J, Samuelsen Ø, Steinbakk M, Abrahamsen TG, Müller F, Gammelsrud KW (2017)
    Impact of extensive antibiotic treatment on faecal carriage of antibiotic-resistant enterobacteria in children in a low resistance prevalence setting
    PLoS One, 12 (11), e0187618
    DOI 10.1371/journal.pone.0187618, PubMed 29112974
  4. Nguyen CB, Alsøe L, Lindvall JM, Sulheim D, Fagermoen E, Winger A, Kaarbø M, Nilsen H, Wyller VB (2017)
    Whole blood gene expression in adolescent chronic fatigue syndrome: an exploratory cross-sectional study suggesting altered B cell differentiation and survival
    J Transl Med, 15 (1), 102
    DOI 10.1186/s12967-017-1201-0, PubMed 28494812
  5. Sand MK, Stubhaug TT, Jørstad ØK (2017)
    [Atypical optic neuritis]
    137 (10), 731
    DOI 10.4045/tidsskr.16.1063, PubMed 28551973
  6. Smeland TE, Müller F, Blomfeldt A, Stavem K, Aamot HV (2017)
    No associations established between single nucleotide polymorphisms in human Toll-like receptor 2 and Toll-interacting protein and Staphylococcus aureus bloodstream infections
    APMIS, 125 (10), 927-932
    DOI 10.1111/apm.12734, PubMed 28736863
  7. Stav-Noraas TE, Edelmann RJ, Poulsen LC, Sundnes O, Phung D, Küchler AM, Müller F, Kamen AA, Haraldsen G, Kaarbø M, Hol J (2017)
    Endothelial IL-33 Expression Is Augmented by Adenoviral Activation of the DNA Damage Machinery
    198 (8), 3318-3325
    DOI 10.4049/jimmunol.1600054, PubMed 28258201

Publications 2016

  1. Blomfeldt A, Aamot HV, Eskesen AN, Müller F, Monecke S (2016)
    Correction for Blomfeldt et al., Molecular Characterization of Methicillin-Sensitive Staphylococcus aureus Isolates from Bacteremic Patients in a Norwegian University Hospital
    54 (9), 2404
    DOI 10.1128/JCM.01436-16, PubMed 27578159
  2. Holter JC, Ueland T, Jenum PA, Müller F, Brunborg C, Frøland SS, Aukrust P, Husebye E, Heggelund L (2016)
    Risk Factors for Long-Term Mortality after Hospitalization for Community-Acquired Pneumonia: A 5-Year Prospective Follow-Up Study
    PLoS One, 11 (2), e0148741
    DOI 10.1371/journal.pone.0148741, PubMed 26849359
  3. Jørgensen SF, Reims HM, Frydenlund D, Holm K, Paulsen V, Michelsen AE, Jørgensen KK, Osnes LT, Bratlie J, Eide TJ, Dahl CP, Holter E, Tronstad RR, Hanevik K, Brattbakk HR, Kaveh F, Fiskerstrand T, Kran AB, Ueland T, Karlsen TH, Aukrust P, Lundin KE, Fevang B (2016)
    A Cross-Sectional Study of the Prevalence of Gastrointestinal Symptoms and Pathology in Patients With Common Variable Immunodeficiency
    111 (10), 1467-1475
    DOI 10.1038/ajg.2016.329, PubMed 27527747
  4. Rosenstierne MW, Karlberg H, Bragstad K, Lindegren G, Stoltz ML, Salata C, Kran AM, Dudman SG, Mirazimi A, Fomsgaard A (2016)
    Rapid Bedside Inactivation of Ebola Virus for Safe Nucleic Acid Tests
    54 (10), 2521-9
    DOI 10.1128/JCM.00346-16, PubMed 27466385
  5. Siljan WW, Holter JC, Nymo SH, Schjalm C, Müller F, Jenum PA, Husebye E, Ueland T, Aukrust P, Mollnes TE, Heggelund L (2016)
    Circulating cell-free DNA is elevated in community-acquired bacterial pneumonia and predicts short-term outcome
    73 (4), 383-6
    DOI 10.1016/j.jinf.2016.07.011, PubMed 27452197
  6. Smedbråten J, Mjøen G, Hartmann A, Åsberg A, Rollag H, Mollnes TE, Sandvik L, Fagerland MW, Thiel S, Sagedal S (2016)
    Low level of MAp44, an inhibitor of the lectin complement pathway, and long-term graft and patient survival; a cohort study of 382 kidney recipients
    BMC Nephrol, 17 (1), 148
    DOI 10.1186/s12882-016-0373-9, PubMed 27760523
  7. Smedbråten J, Sagedal S, Åsberg A, Hartmann A, Rollag H, Mjøen G, Fagerland MW, Hansen SW, Mollnes TE, Thiel S (2016)
    Collectin Liver 1 and Collectin Kidney 1 of the Lectin Complement Pathway Are Associated With Mortality After Kidney Transplantation
    Am J Transplant, 17 (1), 265-271
    DOI 10.1111/ajt.13933, PubMed 27341702
  8. Stubhaug TT, Reiakvam OM, Stensvold CR, Hermansen NO, Holberg-Petersen M, Antal EA, Gaustad K, Førde IS, Heger B (2016)
    Fatal primary amoebic meningoencephalitis in a Norwegian tourist returning from Thailand
    JMM Case Rep, 3 (3), e005042
    DOI 10.1099/jmmcr.0.005042, PubMed 28348761

Publications 2015

  1. Béziat V, Sleiman M, Goodridge JP, Kaarbø M, Liu LL, Rollag H, Ljunggren HG, Zimmer J, Malmberg KJ (2015)
    Polyclonal Expansion of NKG2C(+) NK Cells in TAP-Deficient Patients
    Front Immunol, 6, 507
    DOI 10.3389/fimmu.2015.00507, PubMed 26500647
  2. Broch K, Andreassen AK, Hopp E, Leren TP, Scott H, Müller F, Aakhus S, Gullestad L (2015)
    Results of comprehensive diagnostic work-up in 'idiopathic' dilated cardiomyopathy
    Open Heart, 2 (1), e000271
    DOI 10.1136/openhrt-2015-000271, PubMed 26468400
  3. Hofstra LM, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, Van de Vijver DAMC, Åsjö B, Beshkov D, Coughlan S, Descamps D, Griskevicius A, Hamouda O, Horban A, Van Kasteren M, Kolupajeva T, Kostrikis LG, Liitsola K, Linka M, Mor O, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M et al. (2015)
    Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe
    Clin Infect Dis, 62 (5), 655-663
    DOI 10.1093/cid/civ963, PubMed 26620652
  4. Holter JC, Müller F, Bjørang O, Samdal HH, Marthinsen JB, Jenum PA, Ueland T, Frøland SS, Aukrust P, Husebye E, Heggelund L (2015)
    Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway
    BMC Infect Dis, 15, 64
    DOI 10.1186/s12879-015-0803-5, PubMed 25887603
  5. Kaarbø M, Storm ML, Qu S, Wæhre H, Risberg B, Danielsen HE, Saatcioglu F (2015)
    Correction: TCTP is an androgen-regulated gene implicated in prostate cancer
    PLoS One, 10 (5), e0128727
    DOI 10.1371/journal.pone.0128727, PubMed 25973603
  6. Lisboa LF, Egli A, O'Shea D, Åsberg A, Hartmann A, Rollag H, Pang XL, Tyrrell DL, Kumar D, Humar A (2015)
    Hcmv-miR-UL22A-5p: A Biomarker in Transplantation With Broad Impact on Host Gene Expression and Potential Immunological Implications
    Am J Transplant, 15 (7), 1893-902
    DOI 10.1111/ajt.13222, PubMed 25833298
  7. Pfeiffer HC, Bragstad K, Skram MK, Dahl H, Knudsen PK, Chawla MS, Holberg-Petersen M, Vainio K, Dudman SG, Kran AM, Rojahn AE (2015)
    Two cases of acute severe flaccid myelitis associated with enterovirus D68 infection in children, Norway, autumn 2014
    Euro Surveill, 20 (10), 21062
    DOI 10.2807/1560-7917.es2015.20.10.21062, PubMed 25788251
  8. Rollag H, Holter E, Muller F (2015)
    Hearing loss in children in Ostfold county 2000-09
    Tidsskr. Nor. Laegeforen., 135 (6), 511
  9. Rollag H, Holter E, Müller F (2015)
    [Re: Hearing loss in children in Östfold county 2000-09]
    135 (6), 513
    DOI 10.4045/tidsskr.15.0262, PubMed 25806741
  10. Raastad R, Tvete IF, Abrahamsen TG, Berild D, Leegaard TM, Walberg M, Müller F (2015)
    A worrying trend in weight-adjusted paediatric antibiotic use in a Norwegian tertiary care hospital
    Acta Paediatr, 104 (7), 687-92
    DOI 10.1111/apa.12994, PubMed 25753620
  11. Smedbråten YV, Sagedal S, Mjøen G, Hartmann A, Fagerland MW, Rollag H, Mollnes TE, Thiel S (2015)
    High ficolin-3 level at the time of transplantation is an independent risk factor for graft loss in kidney transplant recipients
    99 (4), 791-6
    DOI 10.1097/TP.0000000000000422, PubMed 25222012
  12. Ueland T, Rollag H, Hartmann A, Jardine A, Humar A, Bignamini AA, Åsberg A, Aukrust P (2015)
    Increased osteoprotegerin predicts poor virological outcome during anticytomegalovirus therapy in solid organ transplant recipients
    99 (1), 100-5
    DOI 10.1097/TP.0000000000000227, PubMed 24983306

Publications 2014

  1. Bragstad K, Jakobsen K, Rojahn AE, Skram MK, Vainio K, Holberg-Petersen M, Hungnes O, Dudman SG, Kran AM (2014)
    High frequency of enterovirus D68 in children hospitalised with respiratory illness in Norway, autumn 2014
    Influenza Other Respir Viruses, 9 (2), 59-63
    DOI 10.1111/irv.12300, PubMed 25534826
  2. Brigtsen AK, Dedi L, Melby KK, Holberg-Petersen M, Radtke A, Lyng RV, Andresen LL, Jacobsen AF, Fugelseth D, Whitelaw A (2014)
    Comparison of PCR and serotyping of Group B Streptococcus in pregnant women: the Oslo GBS-study
    J Microbiol Methods, 108, 31-5
    DOI 10.1016/j.mimet.2014.11.001, PubMed 25447890
  3. Fossum Moen AE, Holberg-Petersen M, Andresen LL, Blomfeldt A (2014)
    spa typing alone is not sufficient to demonstrate endemic establishment of meticillin-resistant Staphylococcus aureus in a low-prevalence country
    88 (2), 72-7
    DOI 10.1016/j.jhin.2014.06.008, PubMed 25085462
  4. Husøy MA, Brinch L, Tjønnfjord GE, Gedde-Dahl T, Heldal D, Holme PA, Dybedal I, Kolstad A, Akkök ÇA, Rollag H, Gaustad P, Bergan S, Egeland T, Josefsen D, Kvalheim G, Fløisand Y (2014)
    [Allogeneic stem-cell transplantation in adults 1985-2012: results and development]
    134 (16), 1569-75
    DOI 10.4045/tidsskr.13.1415, PubMed 25178233
  5. Kran AM (2014)
    [Local food at exotic vacation]
    134 (2), 192-3
    DOI 10.4045/tidsskr.13.1372, PubMed 24477156
  6. Sulheim D, Fagermoen E, Winger A, Andersen AM, Godang K, Müller F, Rowe PC, Saul JP, Skovlund E, Øie MG, Wyller VB (2014)
    Disease mechanisms and clonidine treatment in adolescent chronic fatigue syndrome: a combined cross-sectional and randomized clinical trial
    JAMA Pediatr, 168 (4), 351-60
    DOI 10.1001/jamapediatrics.2013.4647, PubMed 24493300
  7. Taraldsrud E, Fevang B, Aukrust P, Beiske KH, Fløisand Y, Frøland S, Rollag H, Olweus J (2014)
    Common variable immunodeficiency revisited: normal generation of naturally occurring dendritic cells that respond to Toll-like receptors 7 and 9
    175 (3), 439-48
    DOI 10.1111/cei.12239, PubMed 24237110
  8. Turowski G, Rollag H, Roald B (2014)
    Viral infection in placenta relevant cells--a morphological and immunohistochemical cell culture study
    APMIS, 123 (1), 60-4
    DOI 10.1111/apm.12307, PubMed 25244625

Publications 2013

  1. Kaarbø M, Crane DI, Murrell WG (2013)
    RhoA regulation of cardiomyocyte differentiation
    ScientificWorldJournal, 2013, 491546
    DOI 10.1155/2013/491546, PubMed 23935420
  2. Razonable RR, Åsberg A, Rollag H, Duncan J, Boisvert D, Yao JD, Caliendo AM, Humar A, Do TD (2013)
    Virologic suppression measured by a cytomegalovirus (CMV) DNA test calibrated to the World Health Organization international standard is predictive of CMV disease resolution in transplant recipients
    Clin Infect Dis, 56 (11), 1546-53
    DOI 10.1093/cid/cit096, PubMed 23418272
  3. Rollag H, Ueland T, Asberg A, Hartmann A, Jardine AG, Humar A, Pescovitz MD, Bignamini AA, Aukrust P (2013)
    Characterization of cytomegalovirus disease in solid organ transplant recipients by markers of inflammation in plasma
    PLoS One, 8 (4), e60767
    DOI 10.1371/journal.pone.0060767, PubMed 23593305
  4. Smedbråten YV, Sagedal S, Leivestad T, Mjøen G, Osnes K, Rollag H, Reisaeter AV, Foss A, Os I, Hartmann A (2013)
    The impact of early cytomegalovirus infection after kidney transplantation on long-term graft and patient survival
    Clin Transplant, 28 (1), 120-6
    DOI 10.1111/ctr.12288, PubMed 24351078
  5. Touloumi G, Pantazis N, Chaix ML, Bucher HC, Zangerle R, Kran AM, Thiebaut R, Masquelier B, Kucherer C, Monforte Ad, Meyer L, Porter K, for CASCADE Collaboration in EuroCoord (2013)
    Virologic and immunologic response to cART by HIV-1 subtype in the CASCADE collaboration
    PLoS One, 8 (7), e71174
    DOI 10.1371/journal.pone.0071174, PubMed 23936260
  6. Ueland T, Rollag H, Hartmann A, Jardine AG, Humar A, Michelsen AE, Bignamini AA, Åsberg A, Aukrust P (2013)
    Secreted Wnt antagonists during eradication of cytomegalovirus infection in solid organ transplant recipients
    Am J Transplant, 14 (1), 210-5
    DOI 10.1111/ajt.12506, PubMed 24224707

Publications 2012

  1. Aldrin M, Raastad R, Tvete IF, Berild D, Frigessi A, Leegaard T, Monnet DL, Walberg M, Müller F (2012)
    Antibiotic resistance in hospitals: a ward-specific random effect model in a low antibiotic consumption environment
    Stat Med, 32 (8), 1407-18
    DOI 10.1002/sim.5636, PubMed 23027651
  2. Blomfeldt A, Aamot HV, Eskesen AN, Müller F, Monecke S (2012)
    Molecular characterization of methicillin-sensitive Staphylococcus aureus isolates from bacteremic patients in a Norwegian University Hospital
    51 (1), 345-7
    DOI 10.1128/JCM.02571-12, PubMed 23135934
  3. Brantsæter AB, Johannessen A, Holberg-Petersen M, Sandvik L, Naman E, Kivuyo SL, Rollag H, Bruun JN, Kvale D (2012)
    Cytomegalovirus viremia in dried blood spots is associated with an increased risk of death in HIV-infected patients: a cohort study from rural Tanzania
    Int J Infect Dis, 16 (12), e879-85
    DOI 10.1016/j.ijid.2012.08.003, PubMed 23031419
  4. Harboe M, Garred P, Lindstad JK, Pharo A, Müller F, Stahl GL, Lambris JD, Mollnes TE (2012)
    The role of properdin in zymosan- and Escherichia coli-induced complement activation
    189 (5), 2606-13
    DOI 10.4049/jimmunol.1200269, PubMed 22851705
  5. Hausken J, Klingenberg O, Mørkrid L, Rollag H, Foss A, Midtvedt K (2012)
    Elevated troponin I and NT-proBNP at the time of transplantation may predict a major adverse cardiac event in the early postoperative period after renal transplantation
    94 (2), e15-6
    DOI 10.1097/TP.0b013e31825b7633, PubMed 22820562
  6. Quist-Paulsen E, Kran AM, Dunlop O, Wilson J, Ormaasen V (2012)
    Infectious encephalitis: a description of a Norwegian cohort
    45 (3), 179-85
    DOI 10.3109/00365548.2012.719634, PubMed 23113672
  7. Ranneberg-Nilsen T, Rollag H, Slettebakk R, Backe PH, Olsen Ø, Luna L, Bjørås M (2012)
    The chromatin remodeling factor SMARCB1 forms a complex with human cytomegalovirus proteins UL114 and UL44
    PLoS One, 7 (3), e34119
    DOI 10.1371/journal.pone.0034119, PubMed 22479537
  8. Rollag H, Asberg A, Ueland T, Hartmann A, Jardine AG, Humar A, Pescovitz MD, Bignamini AA, Aukrust P (2012)
    Treatment of cytomegalovirus disease in solid organ transplant recipients: markers of inflammation as predictors of outcome
    94 (10), 1060-5
    DOI 10.1097/TP.0b013e31826c39de, PubMed 23104251
  9. Rødland EK, Ueland T, Bjørnsen S, Sagen EL, Dahl CP, Naalsund A, Mollnes TE, Brosstad FR, Müller F, Aukrust P, Frøland SS (2012)
    Systemic biomarkers of inflammation and haemostasis in patients with chronic necrotizing pulmonary aspergillosis
    BMC Infect Dis, 12, 144
    DOI 10.1186/1471-2334-12-144, PubMed 22731696
  10. Touloumi G, Pantazis N, Pillay D, Paraskevis D, Chaix ML, Bucher HC, Kücherer C, Zangerle R, Kran AM, Porter K, CASCADE collaboration in EuroCoord (2012)
    Impact of HIV-1 subtype on CD4 count at HIV seroconversion, rate of decline, and viral load set point in European seroconverter cohorts
    Clin Infect Dis, 56 (6), 888-97
    DOI 10.1093/cid/cis1000, PubMed 23223594

Publications 2011

  1. Asberg A, Jardine AG, Bignamini AA, Rollag H, Gahlemann CC, Humar A, Hartmann A (2011)
    Response to letter about intensity of immunosuppressive therapy on outcome of treatment for CMV disease
    Am J Transplant, 11 (5), 1103-4
    DOI 10.1111/j.1600-6143.2011.03500.x, PubMed 21521477
  2. Brandsaeter BJ, Pillgram M, Berild D, Kjekshus H, Kran AM, Bergersen BM (2011)
    Hospitalised patients with suspected 2009 H1N1 influenza A in a hospital in Norway, July - December 2009
    BMC Infect Dis, 11, 75
    DOI 10.1186/1471-2334-11-75, PubMed 21435254
  3. Duri K, Müller F, Gumbo FZ, Kurewa NE, Rusakaniko S, Chirenje MZ, Mapingure MP, Stray-Pedersen B (2011)
    Human Immunodeficiency Virus (HIV) types Western blot (WB) band profiles as potential surrogate markers of HIV disease progression and predictors of vertical transmission in a cohort of infected but antiretroviral therapy naïve pregnant women in Harare, Zimbabwe
    BMC Infect Dis, 11, 7
    DOI 10.1186/1471-2334-11-7, PubMed 21211021
  4. Kaarbø M, Ager-Wick E, Osenbroch PØ, Kilander A, Skinnes R, Müller F, Eide L (2011)
    Human cytomegalovirus infection increases mitochondrial biogenesis
    Mitochondrion, 11 (6), 935-45
    DOI 10.1016/j.mito.2011.08.008, PubMed 21907833
  5. Lindqvist M, Isaksson B, Grub C, Jonassen TØ, Hällgren A (2011)
    Detection and characterisation of SCCmec remnants in multiresistant methicillin-susceptible Staphylococcus aureus causing a clonal outbreak in a Swedish county
    Eur J Clin Microbiol Infect Dis, 31 (2), 141-7
    DOI 10.1007/s10096-011-1286-y, PubMed 21590357
  6. Lisboa LF, Asberg A, Kumar D, Pang X, Hartmann A, Preiksaitis JK, Pescovitz MD, Rollag H, Jardine AG, Humar A (2011)
    The clinical utility of whole blood versus plasma cytomegalovirus viral load assays for monitoring therapeutic response
    91 (2), 231-6
    DOI 10.1097/TP.0b013e3181ff8719, PubMed 21048530
  7. Lisboa LF, Tong Y, Kumar D, Pang XL, Asberg A, Hartmann A, Rollag H, Jardine AG, Pescovitz MD, Humar A (2011)
    Analysis and clinical correlation of genetic variation in cytomegalovirus
    Transpl Infect Dis, 14 (2), 132-40
    DOI 10.1111/j.1399-3062.2011.00685.x, PubMed 22093996
  8. Myhre HA, Haug Dorenberg D, Kristiansen KI, Rollag H, Leivestad T, Asberg A, Hartmann A (2011)
    Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients
    92 (2), 217-23
    DOI 10.1097/TP.0b013e31821fad25, PubMed 21685829

Publications 2010

  1. Andersen BM, Tollefsen T, Seljordslia B, Hochlin K, Syversen G, Jonassen TØ, Rasch M, Sandvik L (2010)
    Rapid MRSA test in exposed persons: costs and savings in hospitals
    60 (4), 293-9
    DOI 10.1016/j.jinf.2010.01.008, PubMed 20122959
  2. Asberg A, Jardine AG, Bignamini AA, Rollag H, Pescovitz MD, Gahlemann CC, Humar A, Hartmann A, VICTOR Study Group (2010)
    Effects of the intensity of immunosuppressive therapy on outcome of treatment for CMV disease in organ transplant recipients
    Am J Transplant, 10 (8), 1881-8
    DOI 10.1111/j.1600-6143.2010.03114.x, PubMed 20486914
  3. Bratholm C, Johannessen A, Naman E, Gundersen SG, Kivuyo SL, Holberg-Petersen M, Ormaasen V, Bruun JN (2010)
    Drug resistance is widespread among children who receive long-term antiretroviral treatment at a rural Tanzanian hospital
    65 (9), 1996-2000
    DOI 10.1093/jac/dkq234, PubMed 20576637
  4. Cox B, Richardson A, Graham P, Gislefoss RE, Jellum E, Rollag H (2010)
    Breast cancer, cytomegalovirus and Epstein-Barr virus: a nested case-control study
    102 (11), 1665-9
    DOI 10.1038/sj.bjc.6605675, PubMed 20407437
  5. Duri K, Gumbo FZ, Kristiansen KI, Kurewa NE, Mapingure MP, Rusakaniko S, Chirenje MZ, Muller F, Stray-Pedersen B (2010)
    Antenatal HIV-1 RNA load and timing of mother to child transmission; a nested case-control study in a resource poor setting
    Virol J, 7, 176
    DOI 10.1186/1743-422X-7-176, PubMed 20678190
  6. Duri K, Soko W, Gumbo F, Kristiansen K, Mapingure M, Stray-Pedersen B, Muller F, BHAMC Group (2010)
    Genotypic analysis of human immunodeficiency virus type 1 env V3 loop sequences: bioinformatics prediction of coreceptor usage among 28 infected mother-infant pairs in a drug-naive population
    AIDS Res Hum Retroviruses, 27 (4), 411-9
    DOI 10.1089/aid.2010.0142, PubMed 20969460
  7. Grub C, Holberg-Petersen M, Medbø S, Andersen BM, Syversen G, Melby KK (2010)
    A multidrug-resistant, methicillin-susceptible strain of Staphylococcus aureus from a neonatal intensive care unit in Oslo, Norway
    42 (2), 148-51
    DOI 10.3109/00365540903334401, PubMed 19883164
  8. Holberg-Petersen M, Jenum PA, Mannsåker T, Melby KK (2010)
    Comparison of PCR with culture applied on nasopharyngeal and throat swab specimens for the detection of Bordetella pertussis
    43 (3), 221-4
    DOI 10.3109/00365548.2010.538855, PubMed 21108541
  9. Johannessen A, Holberg-Petersen M, Lövgaarden G, Naman E, Ormaasen V, Matee MI, Gundersen SG, Bruun JN (2010)
    HIV type-1 drug resistance testing on dried blood spots is feasible and reliable in patients who fail antiretroviral therapy in rural Tanzania
    Antivir Ther, 15 (7), 1003-9
    DOI 10.3851/IMP1660, PubMed 21041915
  10. Kran AM, Jonassen TO, Sommerfelt MA, Løvgården G, Sørensen B, Kvale D (2010)
    Low frequency of amino acid alterations following therapeutic immunization with HIV-1 Gag p24-like peptides
    AIDS, 24 (17), 2609-18
    DOI 10.1097/QAD.0b013e32833e502b, PubMed 20935558
  11. Rødland EK, Ager-Wick E, Halvorsen B, Müller F, Frøland SS (2010)
    Toll like receptor 5 (TLR5) may be involved in the immunological response to Aspergillus fumigatus in vitro
    Med Mycol, 49 (4), 375-9
    DOI 10.3109/13693786.2010.531772, PubMed 21067314

Publications 2009

  1. Johannessen A, Naman E, Kivuyo SL, Kasubi MJ, Holberg-Petersen M, Matee MI, Gundersen SG, Bruun JN (2009)
    Virological efficacy and emergence of drug resistance in adults on antiretroviral treatment in rural Tanzania
    BMC Infect Dis, 9, 108
    DOI 10.1186/1471-2334-9-108, PubMed 19583845
  2. Kran AM, Jonassen TØ, Sannes M, Jakobsen K, Lind A, Maeland A, Holberg-Petersen M (2009)
    Overestimation of human immunodeficiency virus type 1 load caused by the presence of cells in plasma from plasma preparation tubes
    47 (7), 2170-4
    DOI 10.1128/JCM.00519-09, PubMed 19420166
  3. Merckoll P, Jonassen TØ, Vad ME, Jeansson SL, Melby KK (2009)
    Bacteria, biofilm and honey: a study of the effects of honey on 'planktonic' and biofilm-embedded chronic wound bacteria
    41 (5), 341-7
    DOI 10.1080/00365540902849383, PubMed 19308800
  4. Rødland EK, Ueland T, Pedersen TM, Halvorsen B, Muller F, Aukrust P, Frøland SS (2009)
    Activation of platelets by Aspergillus fumigatus and potential role of platelets in the immunopathogenesis of Aspergillosis
    78 (3), 1269-75
    DOI 10.1128/IAI.01091-09, PubMed 20008537

Publications 2008

  1. Arora S, Jenum PA, Aukrust P, Rollag H, Andreassen AK, Simonsen S, Guide E, Fiane AE, Geiran O, Gullestad L (2008)
    Pre-transplant Toxoplasma gondii seropositivlty among heart transplant recipients and mortality - Reply
    J. Am. Coll. Cardiol., 51 (18), 1827-1828
  2. Dalgard O, Bjøro K, Ring-Larsen H, Bjornsson E, Holberg-Petersen M, Skovlund E, Reichard O, Myrvang B, Sundelöf B, Ritland S, Hellum K, Frydén A, Florholmen J, Verbaan H, North-C Group (2008)
    Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response
    Hepatology, 47 (1), 35-42
    DOI 10.1002/hep.21975, PubMed 17975791
  3. Eskild A, Jeansson S, Jenum PA, Staff AC, Thadhani R, Karumanchi A, Vatten LJ (2008)
    Levels of angiogenic factors in pregnancy and post-partum bleeding
    87 (10), 1081-3
    DOI 10.1080/00016340802415622, PubMed 18792843
  4. Eskild A, Nilsen TI, Jeansson S, Jenum PA, Vatten LJ (2008)
    Serum levels of immunoglobulin E and the subsequent risk of pre-eclampsia: a population-based study
    87 (3), 373-6
    DOI 10.1080/00016340701832687, PubMed 18307080
  5. Maagaard A, Holberg-Petersen M, Løvgården G, Holm M, Pettersen FO, Kvale D (2008)
    Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment
    198 (10), 1474-81
    DOI 10.1086/592713, PubMed 18851688
  6. Nyombi BM, Holm-Hansen C, Kristiansen KI, Bjune G, Müller F (2008)
    Prevalence of reverse transcriptase and protease mutations associated with antiretroviral drug resistance among drug-naïve HIV-1 infected pregnant women in Kagera and Kilimanjaro regions, Tanzania
    AIDS Res Ther, 5, 13
    DOI 10.1186/1742-6405-5-13, PubMed 18570675
  7. Nyombi BM, Kristiansen KI, Bjune G, Müller F, Holm-Hansen C (2008)
    Diversity of human immunodeficiency virus type 1 subtypes in Kagera and Kilimanjaro regions, Tanzania
    AIDS Res Hum Retroviruses, 24 (6), 761-9
    DOI 10.1089/aid.2007.0311, PubMed 18507522
  8. Nyombi BM, Nkya W, Barongo L, Bjune G, Kristiansen KI, Müller F, Holm-Hansen C (2008)
    Evolution of human immunodeficiency virus type 1 serotypes in northern Tanzania: a retrospective study
    APMIS, 116 (6), 507-14
    DOI 10.1111/j.1600-0463.2008.00996.x, PubMed 18754325
  9. Ranneberg-Nilsen T, Dale HA, Luna L, Slettebakk R, Sundheim O, Rollag H, Bjørås M (2008)
    Characterization of human cytomegalovirus uracil DNA glycosylase (UL114) and its interaction with polymerase processivity factor (UL44)
    381 (2), 276-88
    DOI 10.1016/j.jmb.2008.05.028, PubMed 18599070
  10. Rødland EK, Mattingsdal M, Olstad OK, Ovstebø R, Kierulf P, Muller F, Frøland SS (2008)
    Expression of genes in normal human monocytes in response to Aspergillus fumigatus
    Med Mycol, 46 (4), 327-36
    DOI 10.1080/13693780701874507, PubMed 18415839
  11. Vatten LJ, Nilsen TI, Juul A, Jeansson S, Jenum PA, Eskild A (2008)
    Changes in circulating level of IGF-I and IGF-binding protein-1 from the first to second trimester as predictors of preeclampsia
    Eur J Endocrinol, 158 (1), 101-5
    DOI 10.1530/EJE-07-0386, PubMed 18166823

Publications 2007

  1. Anglès d'Auriac M, Refseth UH, Espelund M, Moi H, Størvold G, Jeansson S (2007)
    A new automated method for isolation of Chlamydia trachomatis from urine eliminates inhibition and increases robustness for NAAT systems
    J Microbiol Methods, 70 (3), 416-23
    DOI 10.1016/j.mimet.2007.05.017, PubMed 17610971
  2. Arora S, Jenum PA, Aukrust P, Rollag H, Andreassen AK, Simonsen S, Gude E, Fiane AE, Geiran O, Gullestad L (2007)
    Pre-transplant Toxoplasma gondii seropositivity among heart transplant recipients is associated with an increased risk of all-cause and cardiac mortality
    J Am Coll Cardiol, 50 (20), 1967-72
    DOI 10.1016/j.jacc.2007.07.068, PubMed 17996562
  3. Asberg A, Humar A, Rollag H, Jardine AG, Mouas H, Pescovitz MD, Sgarabotto D, Tuncer M, Noronha IL, Hartmann A, VICTOR Study Group (2007)
    Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients
    Am J Transplant, 7 (9), 2106-13
    DOI 10.1111/j.1600-6143.2007.01910.x, PubMed 17640310
  4. Blomberg B, Manji KP, Urassa WK, Tamim BS, Mwakagile DS, Jureen R, Msangi V, Tellevik MG, Holberg-Petersen M, Harthug S, Maselle SY, Langeland N (2007)
    Antimicrobial resistance predicts death in Tanzanian children with bloodstream infections: a prospective cohort study
    BMC Infect Dis, 7, 43
    DOI 10.1186/1471-2334-7-43, PubMed 17519011
  5. Brantsaeter AB, Holberg-Petersen M, Jeansson S, Goplen AK, Bruun JN (2007)
    CMV quantitative PCR in the diagnosis of CMV disease in patients with HIV-infection - a retrospective autopsy based study
    BMC Infect Dis, 7, 127
    DOI 10.1186/1471-2334-7-127, PubMed 17986346
  6. Maagaard A, Holberg-Petersen M, Torjesen PA, Bruun JN, Kvale D (2007)
    Insulin resistance is affected by increased levels of plasma lactate but not mitochondrial alterations in skeletal muscle in NRTI-exposed HIV-infected patients
    HIV Clin Trials, 8 (5), 345-53
    DOI 10.1310/hct0805-345, PubMed 17956836
  7. Sagedal S, Rollag H, Hartmann A (2007)
    Cytomegalovirus infection in renal transplant recipients is associated with impaired survival irrespective of expected mortality risk
    Clin Transplant, 21 (3), 309-13
    DOI 10.1111/j.1399-0012.2006.00639.x, PubMed 17488378
  8. Thilesen CM, Nicolaidis M, Lökebö JE, Falsen E, Jorde AT, Müller F (2007)
    Leptotrichia amnionii, an emerging pathogen of the female urogenital tract
    45 (7), 2344-7
    DOI 10.1128/JCM.00167-07, PubMed 17522272
  9. Valderhaug TG, Hjelmesaeth J, Rollag H, Leivestad T, Røislien J, Jenssen T, Hartmann A (2007)
    Reduced incidence of new-onset posttransplantation diabetes mellitus during the last decade
    84 (9), 1125-30
    DOI 10.1097/01.tp.0000287191.45032.38, PubMed 17998867
  10. Vatten LJ, Eskild A, Nilsen TI, Jeansson S, Jenum PA, Staff AC (2007)
    Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia
    196 (3), 239.e1-6
    DOI 10.1016/j.ajog.2006.10.909, PubMed 17346536

Publications 2006

  1. Cinek O, Witsø E, Jeansson S, Rasmussen T, Drevinek P, Wetlesen T, Vavrinec J, Grinde B, Rønningen KS (2006)
    Longitudinal observation of enterovirus and adenovirus in stool samples from Norwegian infants with the highest genetic risk of type 1 diabetes
    J Clin Virol, 35 (1), 33-40
    DOI 10.1016/j.jcv.2005.03.007, PubMed 15916916
  2. Dudman SG, Trøseid M, Jonassen TØ, Steinbakk M (2006)
    [Whooping cough--an increasing problem in Norway]
    126 (3), 305-8
    PubMed 16440035
  3. Dyrøy E, Røst TH, Pettersen RJ, Halvorsen B, Gudbrandsen OA, Ueland T, Muna Z, Müller F, Nordrehaug JE, Aukrust P, Berge RK (2006)
    Tetradecylselenoacetic acid, a PPAR ligand with antioxidant, antiinflammatory, and hypolipidemic properties
    Arterioscler Thromb Vasc Biol, 27 (3), 628-34
    DOI 10.1161/01.ATV.0000255950.70774.d5, PubMed 17185614
  4. Kvale EO, Fløisand Y, Lund-Johansen F, Rollag H, Farkas L, Ghanekar S, Brandtzaeg P, Jahnsen FL, Olweus J (2006)
    Plasmacytoid DCs regulate recall responses by rapid induction of IL-10 in memory T cells
    109 (8), 3369-76
    DOI 10.1182/blood-2006-06-031484, PubMed 17158235
  5. Maagaard A, Holberg-Petersen M, Kollberg G, Oldfors A, Sandvik L, Bruun JN (2006)
    Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients
    Antivir Ther, 11 (5), 601-8
    PubMed 16964828
  6. Maagaard A, Holberg-Petersen M, Kvittingen EA, Sandvik L, Bruun JN (2006)
    Depletion of mitochondrial DNA copies/cell in peripheral blood mononuclear cells in HIV-1-infected treatment-naïve patients
    HIV Med, 7 (1), 53-8
    DOI 10.1111/j.1468-1293.2005.00336.x, PubMed 16313293
  7. Ndongmo CB, Pieniazek D, Holberg-Petersen M, Holm-Hansen C, Zekeng L, Jeansson SL, Kaptue L, Kalish ML (2006)
    HIV genetic diversity in Cameroon: possible public health importance
    AIDS Res Hum Retroviruses, 22 (8), 812-6
    DOI 10.1089/aid.2006.22.812, PubMed 16910839
  8. Ranneberg-Nilsen T, Bjørås M, Luna L, Slettebakk R, Dale HA, Seeberg E, Rollag H (2006)
    Human cytomegalovirus infection modulates DNA base excision repair in fibroblast cells
    348 (2), 389-97
    DOI 10.1016/j.virol.2006.01.001, PubMed 16476462
  9. Sandberg WJ, Yndestad A, Øie E, Smith C, Ueland T, Ovchinnikova O, Robertson AK, Müller F, Semb AG, Scholz H, Andreassen AK, Gullestad L, Damås JK, Frøland SS, Hansson GK, Halvorsen B, Aukrust P (2006)
    Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization
    Arterioscler Thromb Vasc Biol, 26 (4), 857-63
    DOI 10.1161/01.ATV.0000204334.48195.6a, PubMed 16424351

Publications 2005

  1. Aukrust P, Luna L, Ueland T, Johansen RF, Müller F, Frøland SS, Seeberg EC, Bjørås M (2005)
    Impaired base excision repair and accumulation of oxidative base lesions in CD4+ T cells of HIV-infected patients
    105 (12), 4730-5
    DOI 10.1182/blood-2004-11-4272, PubMed 15705786
  2. Degré M, Sagedal S, Rollag H (2005)
    Viral infections in immunocompromised patients. A review
    Acta Microbiol Immunol Hung, 52 (3-4), 351-62
    DOI 10.1556/AMicr.52.2005.3-4.7, PubMed 16400875
  3. Hjelmesaeth J, Asberg A, Müller F, Hartmann A, Jenssen T (2005)
    New-onset posttransplantation diabetes mellitus: insulin resistance or insulinopenia? Impact of immunosuppressive drugs, cytomegalovirus and hepatitis C virus infection
    Curr Diabetes Rev, 1 (1), 1-10
    PubMed 18220577
  4. Hjelmesaeth J, Müller F, Jenssen T, Rollag H, Sagedal S, Hartmann A (2005)
    Is there a link between cytomegalovirus infection and new-onset posttransplantation diabetes mellitus? Potential mechanisms of virus induced beta-cell damage
    Nephrol Dial Transplant, 20 (11), 2311-5
    DOI 10.1093/ndt/gfi033, PubMed 16046502
  5. Kvale EØ, Dalgaard J, Lund-Johansen F, Rollag H, Farkas L, Midtvedt K, Jahnsen FL, Brinchmann JE, Olweus J (2005)
    CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection
    107 (5), 2022-9
    DOI 10.1182/blood-2005-05-2016, PubMed 16269620
  6. Sagedal S, Hartmann A, Rollag H (2005)
    The impact of early cytomegalovirus infection and disease in renal transplant recipients
    Clin Microbiol Infect, 11 (7), 518-30
    DOI 10.1111/j.1469-0691.2005.01190.x, PubMed 15966969
  7. Stene-Johansen K, Jonassen TØ, Skaug K (2005)
    Characterization and genetic variability of Hepatitis A virus genotype IIIA
    86 (Pt 10), 2739-45
    DOI 10.1099/vir.0.81155-0, PubMed 16186227
  8. Trøseid M, Jonassen TØ, Steinbakk M (2005)
    Isolation of Bordetella pertussis in blood culture from a patient with multiple myeloma
    52 (1), e11-3
    DOI 10.1016/j.jinf.2005.04.014, PubMed 15936087

Publications 2004

  1. Buzás K, Megyeri K, Miczák A, Fekete A, Degré M, Mándi Y, Rosztóczy I (2004)
    Different staphylococcal strains elicit different levels of production of T-helper 1-inducing cytokines
    Acta Microbiol Immunol Hung, 51 (3), 371-84
    DOI 10.1556/AMicr.51.2004.3.14, PubMed 15571076
  2. Buzás K, Miczák A, Degré M, Megyeri K (2004)
    Rubella virus infection dysregulates the pattern of p63 expression
    APMIS, 112 (10), 656-62
    DOI 10.1111/j.1600-0463.2004.apm1121004.x, PubMed 15601317
  3. Djurovic S, Iversen N, Jeansson S, Hoover F, Christensen G (2004)
    Comparison of nonviral transfection and adeno-associated viral transduction on cardiomyocytes
    Mol Biotechnol, 28 (1), 21-32
    DOI 10.1385/MB:28:1:21, PubMed 15456960
  4. Halvorsen B, Waehre T, Scholz H, Clausen OP, von der Thüsen JH, Müller F, Heimli H, Tonstad S, Hall C, Frøland SS, Biessen EA, Damås JK, Aukrust P (2004)
    Interleukin-10 enhances the oxidized LDL-induced foam cell formation of macrophages by antiapoptotic mechanisms
    46 (2), 211-9
    DOI 10.1194/jlr.M400324-JLR200, PubMed 15547296
  5. Heggelund L, Müller F, Lien E, Yndestad A, Ueland T, Kristiansen KI, Espevik T, Aukrust P, Frøland SS (2004)
    Increased expression of toll-like receptor 2 on monocytes in HIV infection: possible roles in inflammation and viral replication
    Clin Infect Dis, 39 (2), 264-9
    DOI 10.1086/421780, PubMed 15307037
  6. Hjelmesaeth J, Sagedal S, Hartmann A, Rollag H, Egeland T, Hagen M, Nordal KP, Jenssen T (2004)
    Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation
    47 (9), 1550-6
    DOI 10.1007/s00125-004-1499-z, PubMed 15338129
  7. Holm AM, Aukrust P, Damås JK, Müller F, Halvorsen B, Frøland SS (2004)
    Abnormal interleukin-7 function in common variable immunodeficiency
    105 (7), 2887-90
    DOI 10.1182/blood-2004-06-2423, PubMed 15598813
  8. Ormaasen V, Sandvik L, Asjø B, Holberg-Petersen M, Gaarder PI, Bruun JN (2004)
    An algorithm-based genotypic resistance score is associated with clinical outcome in HIV-1-infected adults on antiretroviral therapy
    HIV Med, 5 (6), 400-6
    DOI 10.1111/j.1468-1293.2004.00244.x, PubMed 15544691
  9. Sagedal S, Hartmann A, Nordal KP, Osnes K, Leivestad T, Foss A, Degré M, Fauchald P, Rollag H (2004)
    Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival
    66 (1), 329-37
    DOI 10.1111/j.1523-1755.2004.00735.x, PubMed 15200441

Publications 2003

  1. Aukrust P, Müller F, Svardal AM, Ueland T, Berge RK, Frøland SS (2003)
    Disturbed glutathione metabolism and decreased antioxidant levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy--potential immunomodulatory effects of antioxidants
    188 (2), 232-8
    DOI 10.1086/376459, PubMed 12854078
  2. Bucher A, Olsen P, Müller F (2003)
    [Community-acquired pneumonia--management in hospitals]
    123 (6), 797-9
    PubMed 12693119
  3. Christensen A, Nordbø SA, Jeansson S, Slørdahl S (2003)
    Lower respiratory tract infection caused by human metapneumovirus in two children: the first report of human metapneumovirus infection in Norway
    35 (10), 772-4
    DOI 10.1080/00365540310013306, PubMed 14606624
  4. Dalgard O, Jeansson S, Skaug K, Raknerud N, Bell H (2003)
    Hepatitis C in the general adult population of Oslo: prevalence and clinical spectrum
    38 (8), 864-70
    DOI 10.1080/00365520310004542, PubMed 12940441
  5. Harboe E, Reiersen R, Holberg-Petersen M, Natås OB (2003)
    [Transmission of methicillin resistant Staphylococcus aureus to primary health care workers in a home environment]
    123 (3), 319-21
    PubMed 12640898
  6. Holm AM, Aukrust P, Aandahl EM, Müller F, Taskén K, Frøland SS (2003)
    Impaired secretion of IL-10 by T cells from patients with common variable immunodeficiency--involvement of protein kinase A type I
    170 (11), 5772-7
    DOI 10.4049/jimmunol.170.11.5772, PubMed 12759461
  7. Moen EM, Sagedal S, Bjøro K, Degré M, Opstad PK, Grinde B (2003)
    Effect of immune modulation on TT virus (TTV) and TTV-like-mini-virus (TLMV) viremia
    70 (1), 177-82
    DOI 10.1002/jmv.10356, PubMed 12629661
  8. Msuya SE, Mbizvo E, Hussain A, Sam NE, Jeansson S, Stray-Pedersen B (2003)
    Seroprevalence and correlates of herpes simplex virus type 2 among urban Tanzanian women
    30 (7), 588-92
    DOI 10.1097/00007435-200307000-00011, PubMed 12838089
  9. Nordøy I, Rollag H, Lien E, Sindre H, Degré M, Aukrust P, Frøland SS, Müller F (2003)
    Cytomegalovirus infection induces production of human interleukin-10 in macrophages
    Eur J Clin Microbiol Infect Dis, 22 (12), 737-41
    DOI 10.1007/s10096-003-1028-x, PubMed 14610657
  10. Ormaasen V, Bruun JN, Sandvik L, Holberg-Petersen M, Gaarder PI (2003)
    Prognostic value of changes in CD4 count and HIV RNA during the first six months on highly active antiretroviral therapy in chronic human immunodeficiency virus infection
    35 (6-7), 383-8
    DOI 10.1080/00365540310009716, PubMed 12953949
  11. Sagedal S, Nordal KP, Hartmann A, Midtvedt K, Foss A, Asberg A, Degré M, Fauchald P, Rollag H (2003)
    Pre-emptive therapy of CMVpp65 antigen positive renal transplant recipients with oral ganciclovir: a randomized, comparative study
    Nephrol Dial Transplant, 18 (9), 1899-908
    DOI 10.1093/ndt/gfg302, PubMed 12937241
  12. Synnestvedt M, Müller F, Gaustad P, Bucher A (2003)
    Recurrent group A Streptococcal genital infection after Puerperal sepsis
    35 (8), 509-10
    DOI 10.1080/00365540310013261, PubMed 14514155
  13. Yndestad A, Holm AM, Müller F, Simonsen S, Frøland SS, Gullestad L, Aukrust P (2003)
    Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure
    60 (1), 141-6
    DOI 10.1016/s0008-6363(03)00362-6, PubMed 14522416

Publications 2002

  1. Damås JK, Waehre T, Yndestad A, Ueland T, Müller F, Eiken HG, Holm AM, Halvorsen B, Frøland SS, Gullestad L, Aukrust P (2002)
    Stromal cell-derived factor-1alpha in unstable angina: potential antiinflammatory and matrix-stabilizing effects
    106 (1), 36-42
    DOI 10.1161/01.cir.0000020001.09990.90, PubMed 12093767
  2. Degré M (2002)
    Has cytomegalovirus infection any role in the development of atherosclerosis?
    Clin Microbiol Infect, 8 (4), 191-5
    DOI 10.1046/j.1469-0691.2002.00407.x, PubMed 12047409
  3. Degre M (2002)
    Prevention of post-transfusion cytomegalovirus: leucoreduction or screening?
    Vox Sang., 83 (1), 87
  4. Engelfriet CP, Reesink HW, Hernandez JM, Sauleda S, O'Riordan J, Prati D, Mozzi F, Lin CK, Cuypers HT, Vranckx R, Yoshizawa H, Tomono T, Flanagan P, Sabino EC, Politis C, Tegtmeier GE, Carasa MAV, Hewlett IK, Yu MYW, Epstein JS, Eglin R, Barbara J, Coste J, Cornillot C, Hyland CA et al. (2002)
    Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology
    Vox Sang., 82 (2), 87-111
  5. Eskild A, Jeansson S, Stray-Pedersen B, Jenum PA (2002)
    Herpes simplex virus type-2 infection in pregnancy: no risk of fetal death: results from a nested case-control study within 35,940 women
    BJOG, 109 (9), 1030-5
    PubMed 12269678
  6. Eskild A, Jeansson S, Stray-Pedersen B, Jenum PA (2002)
    Herpes simplex virus type-2 infection in pregnancy: no risk of fetal death: results from a nested case-control study within 35,940 women
    BJOG, 109 (9), PII S1470-0328(02)01934-1-1035
  7. Glosli H, Tronstad KJ, Wergedal H, Müller F, Svardal A, Aukrust P, Berge RK, Prydz H (2002)
    Human TNF-alpha in transgenic mice induces differential changes in redox status and glutathione-regulating enzymes
    FASEB J, 16 (11), 1450-2
    DOI 10.1096/fj.01-0948fje, PubMed 12205044
  8. Megyeri K, Mándi Y, Degré M, Rosztóczy I (2002)
    Induction of cytokine production by different Staphylococcal strains
    Cytokine, 19 (4), 206-12
    DOI 10.1006/cyto.2002.0876, PubMed 12297115
  9. Ormaasen V, Bruun JN, Sandvik L, Holberg-Petersen M, Gaarder PI (2002)
    A search for optimal criteria in initiating antiretroviral therapy in chronic human immunodeficiency virus infection focusing on CD4 count and HIV RNA
    34 (12), 910-7
    DOI 10.1080/0036554021000026957, PubMed 12587624
  10. Reesink HW, Engelfriet CP, Tegtmeier GE, O'Riordan J, Eglin R, Barbara JA, Flanagan P, Lin CK, Rawlinson W, Muylle L, Wendel S, Biagini S, Lazar AE, Krusius T, Alitupa E, Grillner L, Preiser W, Doerr HW, Brand A, Zupanska B, Brojer E, Degré M (2002)
    Prevention of post-transfusion cytomegalovirus: leucoreduction or screening?
    83 (1), 72-87
    DOI 10.1046/j.1423-0410.2002.t01-1-01851.x, PubMed 12100393
  11. Rollag H, Sagedal S, Kristiansen KI, Kvale D, Holter E, Degré M, Nordal KP (2002)
    Cytomegalovirus DNA concentration in plasma predicts development of cytomegalovirus disease in kidney transplant recipients
    Clin Microbiol Infect, 8 (7), 431-4
    DOI 10.1046/j.1469-0691.2002.00449.x, PubMed 12199854
  12. Sagedal S, Nordal KP, Hartmann A, Sund S, Scott H, Degré M, Foss A, Leivestad T, Osnes K, Fauchald P, Rollag H (2002)
    The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients
    Am J Transplant, 2 (9), 850-6
    DOI 10.1034/j.1600-6143.2002.20907.x, PubMed 12392291

Publications 2001

  1. Degré M, Kristiansen KI, Rollag H, Holter E, Nordal KP (2001)
    Detection of human cytomegalovirus (HCMV) pp67-mRNA and pp65 antigenemia in relation to development of clinical HCMV disease in renal transplant recipients
    Clin Microbiol Infect, 7 (5), 254-60
    DOI 10.1046/j.1198-743x.2001.00251.x, PubMed 11422252
  2. Degré M, Ranneberg-Nilsen T, Beck S, Rollag H, Fiane AE (2001)
    Human cytomegalovirus productively infects porcine endothelial cells in vitro
    72 (7), 1334-7
    DOI 10.1097/00007890-200110150-00028, PubMed 11602867
  3. Jeansson S, Kvien TK (2001)
    Acanthamoeba polyphaga in rheumatoid arthritis: possibility for a chronic infection
    53 (6), 610-4
    DOI 10.1046/j.1365-3083.2001.00926.x, PubMed 11422910
  4. Jonassen CM, Jonassen TO, Saif YM, Snodgrass DR, Ushijima H, Shimizu M, Grinde B (2001)
    Comparison of capsid sequences from human and animal astroviruses
    82 (Pt 5), 1061-7
    DOI 10.1099/0022-1317-82-5-1061, PubMed 11297680
  5. Moens U, Van Ghelue M, Kristoffersen AK, Johansen B, Rekvig OP, Degré M, Rollag H (2001)
    Simian virus 40 large T-antigen, but not small T-antigen, trans-activates the human cytomegalovirus major immediate early promoter
    Virus Genes, 23 (2), 215-26
    DOI 10.1023/A:1011877112214, PubMed 11724277
  6. Shadidi KR, Aarvak T, Jeansson S, Henriksen JE, Natvig JB, Thompson KM (2001)
    T-cell responses to viral, bacterial and protozoan antigens in rheumatoid inflammation. Selective migration of T cells to synovial tissue
    Rheumatology (Oxford), 40 (10), 1120-5
    DOI 10.1093/rheumatology/40.10.1120, PubMed 11600741
  7. Trogstad LI, Eskild A, Bruu AL, Jeansson S, Jenum PA (2001)
    Is preeclampsia an infectious disease?
    80 (11), 1036-8
    DOI 10.1034/j.1600-0412.2001.801112.x, PubMed 11703202

Publications 2000

  1. Andenaes S, Lie A, Degré M (2000)
    Prevalence of hepatitis A, B, C, and E antibody in flying airline personnel
    71 (12), 1178-80
    PubMed 11439715
  2. Andenaes S, Lie A, Degre M (2000)
    Prevalence of hepatitis A, B, C, and E antibody in flying airline personnel
    Aviat. Space Environ. Med., 71 (12), 1178-1180
  3. Degré M (2000)
    [Poliomyelitis--a step closer to eradication]
    120 (15), 1718
    PubMed 10904653
  4. Eskild A, Jeansson S, Hagen JA, Jenum PA, Skrondal A (2000)
    Herpes simplex virus type-2 antibodies in pregnant women: the impact of the stage of pregnancy
    Epidemiol Infect, 125 (3), 685-92
    DOI 10.1017/s0950268800004702, PubMed 11218218
  5. Eskild A, Samdal HH, Skaug K, Jeansson S, Stray-Pedersen B, Jenum PA (2000)
    [Hepatitis C virus among pregnant women in Norway--occurrence of antibodies and pregnancy outcome]
    120 (9), 1006-8
    PubMed 10833956
  6. Fiane AE, Mollnes TE, Degré M (2000)
    Pig endogenous retrovirus--a threat to clinical xenotransplantation?
    APMIS, 108 (4), 241-50
    DOI 10.1034/j.1600-0463.2000.d01-51.x, PubMed 10843410
  7. Hungnes O, Jonassen TO, Jonassen CM, Grinde B (2000)
    Molecular epidemiology of viral infections. How sequence information helps us understand the evolution and dissemination of viruses
    APMIS, 108 (2), 81-97
    DOI 10.1034/j.1600-0463.2000.d01-31.x, PubMed 10737453
  8. Nordøy I, Müller F, Nordal KP, Rollag H, Aukrust P, Frøland SS (2000)
    Chemokines and soluble adhesion molecules in renal transplant recipients with cytomegalovirus infection
    120 (2), 333-7
    DOI 10.1046/j.1365-2249.2000.01221.x, PubMed 10792384
  9. Nordøy I, Müller F, Nordal KP, Rollag H, Lien E, Aukrust P, Froland SS (2000)
    The role of the tumor necrosis factor system and interleukin-10 during cytomegalovirus infection in renal transplant recipients
    181 (1), 51-7
    DOI 10.1086/315184, PubMed 10608750
  10. Rustscheff S, Maroti L, Holberg-Petersen M, Steinbakk M, Hoffner SE (2000)
    Mycobacterium interjectum: a new pathogen in humans?
    32 (5), 569-71
    DOI 10.1080/003655400458947, PubMed 11055671
  11. Rustscheff S, Maroti L, Holberg-Petersen M, Steinbakk M, Hoffner SE (2000)
    Mycobacterium interjectum: A new pathogen in humans?
    Scand. J. Infect. Dis., 32 (5), 569-571
  12. Sagedal S, Nordal KP, Hartmann A, Degré M, Holter E, Foss A, Osnes K, Leivestad T, Fauchald P, Rollag H (2000)
    A prospective study of the natural course of cytomegalovirus infection and disease in renal allograft recipients
    70 (8), 1166-74
    DOI 10.1097/00007890-200010270-00007, PubMed 11063335
  13. Sindre H, Haraldsen G, Beck S, Hestdal K, Kvale D, Brandtzaeg P, Degre M, Rollag H (2000)
    Human intestinal endothelium shows high susceptibility to cytomegalovirus and altered expression of adhesion molecules after infection
    Scand. J. Immunol., 51 (4), 354-360
  14. Sindre H, Haraldsen G, Beck S, Hestdal K, Kvale D, Brandtzaeg P, Degré M, Rollag H (2000)
    Human intestinal endothelium shows high susceptibility to cytomegalovirus and altered expression of adhesion molecules after infection
    51 (4), 354-60
    DOI 10.1046/j.1365-3083.2000.00676.x, PubMed 10736107
  15. Sindre H, Rollag H, Degré M, Hestdal K (2000)
    Human cytomegalovirus induced inhibition of hematopoietic cell line growth is initiated by events taking place before translation of viral gene products
    145 (1), 99-111
    DOI 10.1007/s007050050008, PubMed 10664409
  16. Sindre H, Rollag H, Olafsen MK, Degré M, Hestdal K (2000)
    Human cytomegalovirus induces apoptosis in the hematopoietic cell line MO7e
    APMIS, 108 (3), 223-30
    DOI 10.1034/j.1600-0463.2000.d01-48.x, PubMed 10752692
  17. Solheim BG, Rollag H, Svennevig JL (2000)
    Viral safety of solvent/detergent-treated plasma - Reply
    Transfusion, 40 (9), 1150
  18. Solheim BG, Rollag H, Svennevig JL, Arafa O, Fosse E, Bergerud U (2000)
    Viral safety of solvent/detergent-treated plasma
    40 (1), 84-90
    DOI 10.1046/j.1537-2995.2000.40010084.x, PubMed 10644817

Publications 1999

  1. Eskild A, Jeansson S, Jenum PA (1999)
    [Antibodies against Herpes simplex virus type 2 among pregnant women in Norway]
    119 (16), 2323-6
    PubMed 10414195
  2. Grabowska A, Jameson C, Laing P, Jeansson S, Sjögren-Jansson E, Taylor J, Cunningham A, Irving WL (1999)
    Identification of type-specific domains within glycoprotein G of herpes simplex virus type 2 (HSV-2) recognized by the majority of patients infected with HSV-2, but not by those infected with HSV-1
    80 ( Pt 7), 1789-98
    DOI 10.1099/0022-1317-80-7-1789, PubMed 10423148
  3. Holberg-Petersen M, Steinbakk M, Figenschau KJ, Jantzen E, Eng J, Melby KK (1999)
    Identification of clinical isolates of Mycobacterium spp. by sequence analysis of the 16S ribosomal RNA gene. Experience from a clinical laboratory
    APMIS, 107 (2), 231-9
    DOI 10.1111/j.1699-0463.1999.tb01549.x, PubMed 10225322
  4. Nordøy I, Müller F, Nordal KP, Rollag H, Lien E, Aukrust P, Frøland SS (1999)
    Immunologic parameters as predictive factors of cytomegalovirus disease in renal allograft recipients
    180 (1), 195-8
    DOI 10.1086/314849, PubMed 10353879
  5. Skarin T, Becher R, Bucht A, Duvefelt K, Bohm S, Ranneberg-Nilsen T, Lilleaas EM, Schwarze PE, Toftgârd R (1999)
    Cis-acting sequences from the rat cytochrome P450 2B1 gene confer pulmonary and phenobarbital-inducible expression in transgenic mice
    Am J Respir Cell Mol Biol, 21 (2), 177-84
    DOI 10.1165/ajrcmb.21.2.3378, PubMed 10423399

Publications 1998

  1. Bruun T, Kristoffersen AK, Rollag H, Beck S, Degré M (1998)
    Herpes simplex virus type 1 inhibits in vitro differentiation and selected functions of human blood-derived monocytes
    APMIS, 106 (12), 1194-203
    DOI 10.1111/j.1699-0463.1998.tb00277.x, PubMed 10052729
  2. Bruun T, Kristoffersen AK, Rollag H, Degré M (1998)
    Interaction of herpes simplex virus with mononuclear phagocytes is dependent on the differentiation stage of the cells
    APMIS, 106 (2), 305-14
    DOI 10.1111/j.1699-0463.1998.tb01351.x, PubMed 9531964
  3. Eskild A, Jonassen TO, Heger B, Samuelsen SO, Grinde B (1998)
    The estimated impact of the CCR-5 delta32 gene deletion on HIV disease progression varies with study design. Oslo HIV Cohort Study Group
    AIDS, 12 (17), 2271-4
    DOI 10.1097/00002030-199817000-00007, PubMed 9863868
  4. Flugsrud LB, Degré M (1998)
    [Poliomyelitis--the beginning of the end]
    118 (13), 1997-8
    PubMed 9656781
  5. Jenum PA, Holberg-Petersen M, Melby KK, Stray-Pedersen B (1998)
    Diagnosis of congenital Toxoplasma gondii infection by polymerase chain reaction (PCR) on amniotic fluid samples. The Norwegian experience
    APMIS, 106 (7), 680-6
    DOI 10.1111/j.1699-0463.1998.tb00211.x, PubMed 9740505
  6. Jonassen CM, Jonassen TO, Grinde B (1998)
    A common RNA motif in the 3' end of the genomes of astroviruses, avian infectious bronchitis virus and an equine rhinovirus
    79 ( Pt 4), 715-8
    DOI 10.1099/0022-1317-79-4-715, PubMed 9568965
  7. Pelloux H, Guy E, Angelici MC, Aspock H, Bessieres MH, Blatz R, Del Pezzo M, Girault V, Gratzl R, Holberg-Petersen M, Johnson J, Kruger D, Lappalainen M, Naessens A, Olsson M (1998)
    A second European collaborative study on polymerase chain reaction for Toxoplasma gondii, involving 15 teams
    FEMS Microbiol. Lett., 165 (2), 231-237
  8. Pelloux H, Guy E, Angelici MC, Aspöck H, Bessières MH, Blatz R, Del Pezzo M, Girault V, Gratzl R, Holberg-Petersen M, Johnson J, Krüger D, Lappalainen M, Naessens A, Olsson M (1998)
    A second European collaborative study on polymerase chain reaction for Toxoplasma gondii, involving 15 teams
    165 (2), 231-7
    DOI 10.1111/j.1574-6968.1998.tb13151.x, PubMed 9742693
  9. Rollag H, Sagedal S, Holter E, Degré M, Ariansen S, Nordal KP (1998)
    Diagnosis of cytomegalovirus infection in kidney transplant recipients by a quantitative RNA-DNA hybrid capture assay for cytomegalovirus DNA in leukocytes
    Eur J Clin Microbiol Infect Dis, 17 (2), 124-7
    DOI 10.1007/bf01682170, PubMed 9629980
  10. Rollag H, Solheim BG, Svennevig JL (1998)
    Viral safety of blood derivatives by immune neutralization
    74 Suppl 1, 213-7
    DOI 10.1111/j.1423-0410.1998.tb05475.x, PubMed 9789531

Publications 1997

  1. Børsum K, Aksnes J, Müller F, Hagve TA, Kierulf P, Rollag H (1997)
    Modification of mononuclear cell function after incubation with albumin-bound unsaturated fatty acids or soybean oil emulsion
    APMIS, 105 (9), 671-9
    DOI 10.1111/j.1699-0463.1997.tb05070.x, PubMed 9350210
  2. Holberg-Petersen M, Høgåsen AK, Høgåsen K, Abrahamsen TG, Degré M, Rollag H (1997)
    Infection with human cytomegalovirus (HCMV) stimulates monocyte production of complement factor 3
    142 (4), 689-98
    DOI 10.1007/s007050050111, PubMed 9170497
  3. Holberg-Petersen M, Rollag H, Beck S, Degré M (1997)
    The effect of human cytomegalovirus on selected functions of peripheral blood monocytes
    APMIS, 105 (2), 89-98
    DOI 10.1111/j.1699-0463.1997.tb00546.x, PubMed 9113070
  4. Kristoffersen AK, Johnsen JI, Seternes OM, Rollag H, Degré M, Traavik T (1997)
    The human polyomavirus BK T antigen induces gene expression in human cytomegalovirus
    Virus Res, 52 (1), 61-71
    DOI 10.1016/s0168-1702(97)00100-7, PubMed 9453145
  5. Kristoffersen AK, Sindre H, Mándi Y, Rollag H, Degré M (1997)
    Effect of adenovirus 2 on cellular gene activation in blood-derived monocytes and macrophages
    APMIS, 105 (5), 402-9
    DOI 10.1111/j.1699-0463.1997.tb00587.x, PubMed 9201242
  6. Monceyron C, Grinde B, Jonassen TO (1997)
    Molecular characterisation of the 3'-end of the astrovirus genome
    142 (4), 699-706
    DOI 10.1007/s007050050112, PubMed 9170498

Publications 1996

  1. Aksnes J, Børsum K, Rollag H, Hovig T (1996)
    Intravascular lung macrophages play an essential role in lipid entrapment and the inflammatory tissue reaction seen after long-term lipid-based parenteral nutrition in pigs. An ultrastructural study
    APMIS, 104 (6), 429-36
    DOI 10.1111/j.1699-0463.1996.tb00738.x, PubMed 8774672
  2. Degré M (1996)
    Cytokines and bacterial infections
    Biotherapy, 8 (3-4), 219-28
    DOI 10.1007/BF01877208, PubMed 8813334
  3. Degré M (1996)
    Interferons and other cytokines in bacterial infections
    J Interferon Cytokine Res, 16 (6), 417-26
    DOI 10.1089/jir.1996.16.417, PubMed 8807494
  4. Dousset N, Moatti JP, Moatti N, Degré M, Eche B, Gasset G, Tixador R (1996)
    Influence of the environment in space on the biochemical characteristics of human low density lipoproteins
    Free Radic Res, 24 (1), 69-74
    DOI 10.3109/10715769609088001, PubMed 8747894
  5. Grinde B, Jonassen TO (1996)
    [The HIV proteinase--a target for antiviral agents]
    116 (24), 2908-11
    PubMed 8975409
  6. Haug CJ, Müller F, Rollag H, Aukrust P, Degré M, Frøland SS (1996)
    The effect of 1,25-vitamin D3 on maturation of monocytes from HIV-infected patients varies with degree of immunodeficiency
    APMIS, 104 (7-8), 539-48
    DOI 10.1111/j.1699-0463.1996.tb04909.x, PubMed 8920807
  7. Holberg-Petersen M, Bukholm G, Haarr L, Langeland N, Degré M (1996)
    Human interferon reduces surface expression but not total production of herpes simplex virus type 1 glycoproteins gC and gE in heterologous hamster cells
    J Interferon Cytokine Res, 16 (9), 717-24
    DOI 10.1089/jir.1996.16.717, PubMed 8887056
  8. Holberg-Petersen M, Rollag H, Beck S, Overli I, Tjønnfjord G, Abrahamsen TG, Degré M, Hestdal K (1996)
    Direct growth suppression of myeloid bone marrow progenitor cells but not cord blood progenitors by human cytomegalovirus in vitro
    88 (7), 2510-6
    PubMed 8839843
  9. HolbergPetersen M, Rollag H, Beck S, Overli I, Tjonnfjord G, Abrahamsen TG, Degre M, Hestdal K (1996)
    Direct growth suppression of myeloid bone marrow progenitor cells but not cord blood progenitors by human cytomegalovirus in vitro
    Blood, 88 (7), 2510-2516
  10. Sindre H, Tjonnfjord GE, Rollag H, RannebergNilsen T, Veiby OP, Beck S, Degre M, Hestdal K (1996)
    Human cytomegalovirus suppression of and latency in early hematopoietic progenitor cells
    Blood, 88 (12), 4526-4533
  11. Sindre H, Tjøonnfjord GE, Rollag H, Ranneberg-Nilsen T, Veiby OP, Beck S, Degré M, Hestdal K (1996)
    Human cytomegalovirus suppression of and latency in early hematopoietic progenitor cells
    88 (12), 4526-33
    PubMed 8977244

Publications 1995

  1. Aksnes J, Børsum K, Hagve TA, Kierulf P, Müller F, Rollag H (1995)
    Long-term lipid-based total parenteral nutrition activates mononuclear cells and modulates membrane lipid composition in pigs
    55 (3), 201-10
    DOI 10.3109/00365519509089614, PubMed 7638553
  2. Bukholm G, Rollag H (1995)
    [Revolution in diagnostic microbiology. Needs, driving forces and consequences]
    115 (27), 3387-9
    PubMed 7491583
  3. Degré M (1995)
    [Transmissible spongiform encephalopathies--an unconventional contagious agent]
    115 (25), 3137-40
    PubMed 8539696
  4. Degré M (1995)
    [Infectious diseases--new and old, in new forms]
    115 (23), 2875-6
    PubMed 7570504
  5. Degré M, Bukholm G (1995)
    Orally administered interferon-gamma but not tumor necrosis factor-alpha suppress infection with Salmonella typhimurium in a mouse model
    J Biol Regul Homeost Agents, 9 (1), 15-20
    PubMed 8553903
  6. Dueland AN, Ranneberg-Nilsen T, Degré M (1995)
    Detection of latent varicella zoster virus DNA and human gene sequences in human trigeminal ganglia by in situ amplification combined with in situ hybridization
    140 (11), 2055-66
    DOI 10.1007/bf01322692, PubMed 7503701
  7. Evensen SA, Rollag H, Glomstein A (1995)
    Hepatitis C virus seroconversion in a hemophiliac treated exclusively with solvent/detergent-treated clotting factor concentrate
    Eur J Clin Microbiol Infect Dis, 14 (7), 631-2
    DOI 10.1007/bf01690743, PubMed 7588856
  8. Grinde B, Jonassen TO, Ushijima H (1995)
    Sensitive detection of group A rotaviruses by immunomagnetic separation and reverse transcription-polymerase chain reaction
    55 (3), 327-38
    DOI 10.1016/0166-0934(95)00070-x, PubMed 8609198
  9. Moatti JP, Dousset N, Moatti N, Degre M, Eche B, Gasset G, Tixador R (1995)
    ESA's Biopan 1--"Vitamin" experiment preliminary results
    36 (8-12), 527-33
    PubMed 11540984
  10. Modalsli KR, Bukholm G, Holberg-Petersen M, Degré M (1995)
    Shigella flexneri adherence to and multiplication in coxsackie B1 virus-infected HEp-2 cells
    APMIS, 103 (4), 254-60
    DOI 10.1111/j.1699-0463.1995.tb01103.x, PubMed 7612255
  11. Trybala E, Bergström T, Olofsson S, Svennerholm B, Jeansson S (1995)
    An evaluation of a hemagglutination-inhibition test for the detection of antibodies to herpes simplex virus type 1
    Clin Diagn Virol, 3 (2), 191-201
    DOI 10.1016/0928-0197(94)00030-X, PubMed 15566801
  12. ULSTRUP JC, JEANSSON S, WIKER HG, HARBOE M (1995)
    RELATIONSHIP OF SECRETION PATTERN AND MPB70 HOMOLOGY WITH OSTEOBLAST-SPECIFIC FACTOR-2 TO OSTEITIS FOLLOWING MYCOBACTERIUM-BOVIS BCG VACCINATION
    Infect. Immun., 63 (2), 672-675
  13. Ulstrup JC, Jeansson S, Wiker HG, Harboe M (1995)
    Relationship of secretion pattern and MPB70 homology with osteoblast-specific factor 2 to osteitis following Mycobacterium bovis BCG vaccination
    63 (2), 672-5
    PubMed 7822037

Publications 1994

  1. Degré M, Beck S (1994)
    Anti-HIV activity of dideoxynucleosides, foscarnet and fusidic acid is potentiated by human leukocyte interferon in blood-derived macrophages
    40 (3), 201-8
    DOI 10.1159/000239193, PubMed 7515781
  2. Degré M, Bukholm G, Holter E, Müller F, Rollag H (1994)
    Rapid detection of cytomegalovirus infection in immunocompromised patients
    Eur J Clin Microbiol Infect Dis, 13 (8), 668-70
    DOI 10.1007/bf01973997, PubMed 7813501
  3. FAUCHALD P, LEIVESTAD T, ROLLAG H, ALBRECHTSEN D, SODAL G (1994)
    INFLUENCE OF CYTOMEGALOVIRUS ANTIBODY STATUS ON GRAFT-SURVIVAL IN RENAL-TRANSPLANTATION
    Transplant. Proc., 26 (3), 1725
  4. Fauchald P, Leivestad T, Rollag H, Albrechtsen D, Sødal G (1994)
    Influence of cytomegalovirus antibody status on graft survival in renal transplantation
    26 (3), 1725
    PubMed 8030103
  5. Holberg-Petersen M, Bukholm G, Rollag H, Degré M (1994)
    Infection with human cytomegalovirus enhances bacterial adhesiveness and invasiveness in permissive and semipermissive cells
    APMIS, 102 (9), 703-10
    DOI 10.1111/j.1699-0463.1994.tb05223.x, PubMed 7946274
  6. Kristoffersen AK, Taskèn K, Rollag H (1994)
    Expression of protein kinase A and protein kinase C during ongoing human cytomegalovirus infection
    138 (1-2), 85-93
    DOI 10.1007/bf01310040, PubMed 7980013
  7. Skaug K, Jonassen TO, Figenschau KJ (1994)
    [New cases of HIV infection. Estimation of the time of transmission]
    114 (18), 2099-101
    PubMed 7992264
  8. Tigalonova M, Bjerke JR, Gallati H, Degré M, Jablonska S, Majewski S, Matre R (1994)
    Serum levels of interferons and TNF-alpha are not correlated to psoriasis activity and therapy
    186, 25-7
    DOI 10.2340/000155551862527, PubMed 8073829
  9. TIGALONOVA M, BJERKE JR, GALLATI H, DEGRE M, JABLONSKA S, MAJEWSKI S, MATRE R (1994)
    SERUM LEVELS OF INTERFERONS AND TNF-ALPHA ARE NOT CORRELATED TO PSORIASIS ACTIVITY AND THERAPY
    Acta Derm.-Venereol., 74 186, 25-27

Publications 1993

  1. Evensen SA, Rollag H (1993)
    Solvent/detergent-treated clotting factors and hepatitis A virus seroconversion
    341 (8850), 971-2
    DOI 10.1016/0140-6736(93)91273-o, PubMed 8096316
  2. Foerster A, Bjørtuft O, Geiran O, Rollag H, Leivestad T, Frøysaker T (1993)
    Single lung transplantation. Morphological surveillance by transbronchial biopsy
    APMIS, 101 (6), 455-66
    DOI 10.1111/j.1699-0463.1993.tb00134.x, PubMed 8395861
  3. Hansen TW, Gaustad P, Rollag H, Abrahamsen TG, Finne PH (1993)
    [Diagnosis and treatment of infections in a neonatal unit--viral infections, spirochete infections and toxoplasma infections]
    113 (14), 1701-5
    PubMed 8322295
  4. Li H, Ulstrup JC, Jonassen TO, Melby K, Nagai S, Harboe M (1993)
    Evidence for absence of the MPB64 gene in some substrains of Mycobacterium bovis BCG
    61 (5), 1730-4
    PubMed 8478061
  5. Modalsli KR, Mikalsen SO, Bukholm G, Degré M (1993)
    Microinjection of HEp-2 cells with coxsackie B1 virus RNA enhances invasiveness of Shigella flexneri only after prestimulation with UV-inactivated virus
    APMIS, 101 (8), 602-6
    DOI 10.1111/j.1699-0463.1993.tb00153.x, PubMed 8217113
  6. Rollag H, Thorvaldsen J, Kittelsen P, Bjøro K, Frøland S (1993)
    [Hepatitis C virus infections among persons attending special clinics dealing with problems related to social conditions]
    113 (19), 2397-400
    PubMed 7690995
  7. Skaug K, Li H, Jonassen TO, Larsen J, Figenschau KJ (1993)
    Hepatitis C virus (HCV) RNA among anti-HCV-positive blood donors and their recipients
    64 (4), 215-9
    DOI 10.1111/j.1423-0410.1993.tb03058.x, PubMed 7685969
  8. SOLHEIM BG, SVENNEVIG JL, MOHR B, DRAGSUND M, NODDELAND H, TOLLEFSRUD S, BROSSTAD F, ROLLAG H, MOLLNES TE (1993)
    THE USE OF OCTAPLAS IN PATIENTS UNDERGOING OPEN-HEART-SURGERY
    INT CONGR SER, 1044, 253-262
  9. Stenseth AM, Rollag H, Degré M (1993)
    Effect of in vitro acyclovir treatment on selected functions of blood-derived macrophages
    39 (3), 197-202
    DOI 10.1159/000239126, PubMed 8508690

Publications 1992

  1. Bell H, Raknerud N, Try K, Jonassen TO, Skaug K, Størvold G, Roald B, Kuo G (1992)
    [Chronic hepatitis C. Experience with 50 patients]
    112 (23), 2953-7
    PubMed 1329264
  2. Degré M (1992)
    [Prevention and treatment of influenza]
    112 (16), 2052
    PubMed 1523619
  3. Degré M, Beck S, Rollag H (1992)
    Interferon-gamma may enhance infection of blood-derived macrophages with HIV-1 in the presence of HIV-positive serum
    APMIS, 100 (5), 465-9
    DOI 10.1111/j.1699-0463.1992.tb00898.x, PubMed 1586484
  4. Gundersen SG, Haagensen I, Jonassen TO, Figenschau KJ, de Jonge N, Deelder AM (1992)
    Quantitative detection of schistosomal circulating anodic antigen by a magnetic bead antigen capture enzyme-linked immunosorbent assay (MBAC-EIA) before and after mass chemotherapy
    86 (2), 175-8
    DOI 10.1016/0035-9203(92)90559-u, PubMed 1440781
  5. Gundersen SG, Haagensen I, Jonassen TO, Figenschau KJ, de Jonge N, Deelder AM (1992)
    Magnetic bead antigen capture enzyme-linked immunoassay in microtitre trays for rapid detection of schistosomal circulating anodic antigen
    148 (1-2), 1-8
    DOI 10.1016/0022-1759(92)90151-i, PubMed 1564319
  6. Modalsli K, Bukholm G, Degré M (1992)
    Interferon treatment reduced adherence, invasiveness and intracellular multiplication of Shigella flexneri in coxsackie B1 virus-infected cells
    J Biol Regul Homeost Agents, 6 (2), 35-45
    PubMed 1329437
  7. Modalsli K, Bukholm G, Mikalsen SO, Degré M (1992)
    Coxsackie B1 virus-induced changes in cell membrane-associated functions are not responsible for altered sensitivity to bacterial invasiveness
    124 (3-4), 321-32
    DOI 10.1007/bf01309812, PubMed 1318709
  8. Modalsli K, Bukholm G, Mikalsen SO, Degré M (1992)
    Correlation between Coxsackie B1 virus replication and enhanced invasiveness of Shigella flexneri
    APMIS, 100 (3), 237-45
    DOI 10.1111/j.1699-0463.1992.tb00866.x, PubMed 1314061
  9. Müller F, Holberg-Petersen M, Rollag H, Degré M, Brandtzaeg P, Frøland SS (1992)
    Nonspecific oral immunity in individuals with HIV infection
    J Acquir Immune Defic Syndr, 5 (1), 46-51
    PubMed 1371157

Publications 1991

  1. Brinch L, Evensen SA, Albrechtsen D, Egeland T, Solheim BG, Rollag H, Naalsund A, Jacobsen AB (1991)
    [Allogeneic bone marrow transplantation in adults. Results after fractionated whole body irradiation and high dosage cyclophosphamide and use of HLA-compatible sibling donors]
    111 (3), 311-5
    PubMed 2000610
  2. Degré M (1991)
    [Virologic rapid diagnosis]
    111 (15), 1866
    PubMed 1853322
  3. Degré M (1991)
    [Antiviral agents for the systemic treatment of herpesvirus infections]
    111 (21), 2663-4
    PubMed 1658971
  4. Degré M, Rollag H, Holter E, Tønjum T, Krajci Z, Bukholm G (1991)
    [Diagnosis of cytomegalovirus infections in hospitalized patients]
    111 (28), 3401-4
    PubMed 1665258
  5. Holberg-Petersen M, Böhmer E, Namork E, Degré M (1991)
    Effect of interferon treatment on expression of gC and gE glycoproteins in herpes simplex virus-infected cells
    APMIS, 99 (4), 307-15
    DOI 10.1111/j.1699-0463.1991.tb05154.x, PubMed 1645168
  6. Lund MB, Simonsen S, Foerster A, Rollag H, Geiran O (1991)
    [Gastrointestinal cytomegalovirus infection in patients with heart transplants]
    111 (28), 3385-7
    PubMed 1665254
  7. Mándi Y, Endrész V, Krenács L, Régely K, Degré M, Béládi I (1991)
    Tumor necrosis factor production by human granulocytes
    96 (2), 102-6
    DOI 10.1159/000235479, PubMed 1769740
  8. Modalsli KR, Bukholm G, Mikalsen SO, Degré M (1991)
    Microinjected Coxsackie B1 virus does not replicate in HEp-2 cells
    185 (2), 888-90
    DOI 10.1016/0042-6822(91)90566-t, PubMed 1660207
  9. Rollag H, Patou G, Pattison JR, Degré M, Evensen SA, Fröland SS, Glomstein A (1991)
    Prevalence of antibodies against parvovirus B19 in Norwegians with congenital coagulation factor defects treated with plasma products from small donor pools
    23 (6), 675-9
    DOI 10.3109/00365549109024292, PubMed 1815327

Publications 1990

  1. Bukholm G, Degré M, Whitaker-Dowling P (1990)
    Interferon treatment reduces endocytosis of virus and facultatively intracellular bacteria in various cell lines
    10 (1), 83-9
    PubMed 1691770
  2. BUKHOLM G, DEGRE M, WHITAKERDOWLING P (1990)
    INTERFERON TREATMENT REDUCES ENDOCYTOSIS OF VIRUS AND FACULTATIVELY INTRACELLULAR BACTERIA IN VARIOUS CELL-LINES
    J. Interferon Res., 10 (1), 83-89
  3. Dahl-Hansen E, Siebke JC, Frøland SS, Degré M (1990)
    Immunogenicity of yeast-derived hepatitis B vaccine from two different producers
    Epidemiol Infect, 104 (1), 143-9
    DOI 10.1017/s0950268800054625, PubMed 2137785
  4. Degré M (1990)
    [Latent and activated viral infections]
    110 (21), 2747-8
    PubMed 2219044
  5. Degré M, Bukholm G (1990)
    Effect of tumor necrosis factor-alpha on infection with Salmonella typhimurium in a mouse model
    J Biol Regul Homeost Agents, 4 (4), 157-61
    PubMed 2128989
  6. Modalsli K, Bukholm G, Degré M (1990)
    Coxsackie B1 virus infection enhances the bacterial invasiveness, the phagocytosis and the membrane permeability in HEp-2 cells
    APMIS, 98 (6), 489-95
    DOI 10.1111/j.1699-0463.1990.tb01061.x, PubMed 2166540
  7. MULLER F, ROLLAG H, FROLAND SS (1990)
    REDUCED OXIDATIVE BURST RESPONSES IN MONOCYTES AND MONOCYTE-DERIVED MACROPHAGES FROM HIV-INFECTED SUBJECTS
    Clin. Exp. Immunol., 82 (1), 10-15
  8. MULLER F, ROLLAG H, GAUDERNACK G, FROLAND SS (1990)
    IMPAIRED INVITRO SURVIVAL OF MONOCYTES FROM PATIENTS WITH HIV-INFECTION
    Clin. Exp. Immunol., 81 (1), 25-30
  9. Müller F, Rollag H, Frøland SS (1990)
    Effects of alpha- and beta-interferon on oxidative burst responses of monocytes and monocyte-derived macrophages from patients with HIV infection
    J Biol Regul Homeost Agents, 4 (3), 93-7
    PubMed 2135379
  10. Müller F, Rollag H, Frøland SS (1990)
    Reduced oxidative burst responses in monocytes and monocyte-derived macrophages from HIV-infected subjects
    82 (1), 10-5
    DOI 10.1111/j.1365-2249.1990.tb05396.x, PubMed 1976461
  11. Müller F, Rollag H, Gaudernack G, Frøland SS (1990)
    Impaired in vitro survival of monocytes from patients with HIV infection
    81 (1), 25-30
    DOI 10.1111/j.1365-2249.1990.tb05286.x, PubMed 1974179
  12. Rollag H, Evensen SA, Frøland SS, Glomstein A (1990)
    Serological markers of hepatitis B virus and cytomegalovirus infections in Norwegians with coagulation factor defects
    60 (2), 93-6
    DOI 10.1007/bf01720514, PubMed 2154272
  13. Rollag H, Evesen SA, Fröland SS, Glomstein A (1990)
    Prevalence of antibodies against hepatitis C virus in Norwegians with congenital coagulation factor defects treated with plasma products from small pools
    Eur J Clin Microbiol Infect Dis, 9 (8), 612-4
    DOI 10.1007/bf01967219, PubMed 2170135
  14. Schrumpf E, Elgjo K, Fausa O, Haukenes G, Kvale D, Rollag H (1990)
    The significance of anti-hepatitis C virus antibodies measured in chronic liver disease
    25 (11), 1169-74
    DOI 10.3109/00365529008998550, PubMed 2177219

Publications 1989

  1. Brinchmann JE, Gaudernack G, Thorsby E, Jonassen TO, Vartdal F (1989)
    Reliable isolation of human immunodeficiency virus from cultures of naturally infected CD4+ T cells
    25 (3), 293-300
    DOI 10.1016/0166-0934(89)90056-6, PubMed 2573612
  2. Degré M, Bukholm G, Czarniecki CW (1989)
    In vitro treatment of HEp-2 cells with human tumor necrosis factor-alpha and human interferons reduces invasiveness of Salmonella typhimurium
    J Biol Regul Homeost Agents, 3 (1), 1-7
    PubMed 2472042
  3. Maehlen T, Degré M (1989)
    Lack of activity of fusidic acid against human immunodeficiency virus in monocytes
    33 (5), 680-3
    DOI 10.1128/aac.33.5.680, PubMed 2473711
  4. Mándi Y, Degré M, Béládi I (1989)
    Involvement of tumor necrosis factor in human granulocyte-mediated killing of WEHI 164 cells
    90 (4), 411-3
    DOI 10.1159/000235063, PubMed 2613348
  5. Müller F, Rollag H, Frøland SS (1989)
    Nitroblue tetrazolium reduction in monocytes and monocyte-derived macrophages. Effect of oxidative burst stimulants and interferons
    APMIS, 97 (6), 490-6
    DOI 10.1111/j.1699-0463.1989.tb00821.x, PubMed 2472158
  6. Orstavik I, Siebke JC, Rollag H, Skaug K, Størvold G, Orjasoeter H (1989)
    [Anti-hepatitis C (HCV) ELISA. A serologic test for non-A non-B hepatitis (NANBH) after blood transfusion]
    109 (34-36), 3648
    PubMed 2515616
  7. Rollag H, Degré M (1989)
    Phagocytic activity and protein content of human monocytes cultivated in the presence of various homologous interferon preparations
    J Biol Regul Homeost Agents, 3 (1), 39-44
    PubMed 2472044
  8. Schmidt H, Bukholm G, Holberg-Petersen M (1989)
    Adhesiveness and invasiveness of staphylococcal species in a cell culture model
    APMIS, 97 (7), 655-60
    DOI 10.1111/j.1699-0463.1989.tb00457.x, PubMed 2751900

Publications 1988

  1. Bukholm G, Bergh M, Degré M (1988)
    Interferon treatment of HEp-2 cells alters the adhesive ability of Pseudomonas aeruginosa
    APMIS, 96 (11), 1043-8
    DOI 10.1111/j.1699-0463.1988.tb00979.x, PubMed 2461717
  2. Bukholm G, Bjørnland K, Ellekjaer H, Berdal BP, Degré M (1988)
    Vesicular stomatitis virus infection enhances invasiveness of Salmonella typhimurium
    APMIS, 96 (5), 400-6
    DOI 10.1111/j.1699-0463.1988.tb05322.x, PubMed 2837253
  3. Bukholm G, Degré M (1988)
    Shiga toxin inhibits the anti-invasive effect of interferons
    157 (4), 849-50
    DOI 10.1093/infdis/157.4.849, PubMed 2450154
  4. Degré M, Bukholm G (1988)
    Effects of interferon and tumour necrosis factor on development of intracellular bacterial infections
    Acta Microbiol Hung, 35 (4), 405-10
    PubMed 2469282
  5. Ekgren J, Norling BK, Degre M, Midtvedt T (1988)
    Comparison of tinidazole given as a single dose and on 2 consecutive days for the treatment of nonspecific bacterial vaginosis
    26 (4), 313-7
    DOI 10.1159/000293712, PubMed 3068098
  6. Høeg V, Schrumpf E, Blomhoff JP, Frøland S, Rollag H, Stokke O, Aasen AO (1988)
    [Etiology of chronic pancreatitis]
    108 (31), 2834-7
    PubMed 3201447
  7. LAPPEGARD KT, BENESTAD HB, ROLLAG H (1988)
    INTERFERONS AFFECT OXYGEN-METABOLISM IN HUMAN NEUTROPHIL GRANULOCYTES
    J. Interferon Res., 8 (5), 665-677
  8. Lappegård KT, Benestad HB, Rollag H (1988)
    Interferons affect oxygen metabolism in human neutrophil granulocytes
    8 (5), 665-77
    PubMed 2466914
  9. Oftung F, Mustafa AS, Shinnick TM, Houghten RA, Kvalheim G, Degre M, Lundin KE, Godal T (1988)
    Epitopes of the Mycobacterium tuberculosis 65-kilodalton protein antigen as recognized by human T cells
    141 (8), 2749-54
    PubMed 2459228
  10. OFTUNG F, MUSTAFA AS, SHINNICK TM, HOUGHTEN RA, KVALHEIM G, DEGRE M, LUNDIN KEA, GODAL T (1988)
    EPITOPES OF THE MYCOBACTERIUM-TUBERCULOSIS 65-KILODALTON PROTEIN ANTIGEN AS RECOGNIZED BY HUMAN T-CELLS
    J. Immunol., 141 (8), 2749-2754
  11. ROLLAG H, DEGRE M (1988)
    EFFECT OF RECOMBINANT INTERFERON-GAMMA ON PROTEIN-CONTENT, PHAGOCYTIC, AND CYTO-TOXIC ACTIVITY OF MOUSE PERITONEAL-MACROPHAGES
    J. Interferon Res., 8 (2), 169-178
  12. Rollag H, Degré M (1988)
    Effect of recombinant interferon-gamma on protein content, phagocytic, and cytotoxic activity of mouse peritoneal macrophages
    8 (2), 169-78
    PubMed 3132510
  13. Rollag H, Mørland B (1988)
    The effect of recombinant interferons on cathepsin B activity in human monocytes
    76, 79-83
    PubMed 2472002
  14. Skar AG, Middeldorp J, Gundersen T, Rollag H, Degrè M (1988)
    Rapid diagnosis of genital herpes simplex infection by an indirect ELISA method
    11 (2), 59-65
    PubMed 3247065

Publications 1987

  1. Albrechtsen DH, Evensen SA, Frøland S, Stavem P, Lie SO, Steinbakk M, Rollag H, Solheim B, Thorsby E, Jacobsen AB (1987)
    [Allogeneic bone marrow transplantation in Norway]
    107 (26), 2222-4
    PubMed 3313797
  2. Austgulen R, Nissen-Meyer J, Degré M, Espevik T (1987)
    Monocyte-derived influence on growth of normal human fibroblasts. The contribution of tumour necrosis factor to growth inhibition
    26 (2), 175-85
    DOI 10.1111/j.1365-3083.1987.tb02249.x, PubMed 3114873
  3. Bukholm G, Bergh M, Degré M (1987)
    Interferon-induced protein synthesis inhibits endocytosis of bacteria in epithelial cells
    7 (4), 409-17
    PubMed 3312425
  4. BUKHOLM G, BERGH M, DEGRE M (1987)
    INTERFERON-INDUCED PROTEIN-SYNTHESIS INHIBITS ENDOCYTOSIS OF BACTERIA IN EPITHELIAL-CELLS
    J. Interferon Res., 7 (4), 409-417
  5. Evensen SA, Ulstrup J, Skaug K, Frøland SS, Glomstein A, Rollag H (1987)
    HIV infection in Norwegian haemophiliacs: the prevalence of antibodies against HIV in haemophiliacs treated with lyophilized cryoprecipitate from volunteer donors
    Eur J Haematol, 39 (1), 44-8
    DOI 10.1111/j.1600-0609.1987.tb00162.x, PubMed 3115823
  6. Grinde B, Jonassen TO (1987)
    Methionine is a regulator of starvation-induced proteolysis in Tetrahymena
    173 (2), 496-503
    DOI 10.1016/0014-4827(87)90289-8, PubMed 3691671
  7. Livden JK, Bjerke JR, Degre M, Krogh HK, Matre R (1987)
    The significance of interferon in photoimmunology
    134, 43-6
    PubMed 2451386
  8. Livden JK, Bjerke JR, Degre M, Matre R (1987)
    Effect of UV radiation on interferon, immunoglobulins and complement components in serum from healthy individuals
    Photodermatol, 4 (6), 296-301
    PubMed 2451236
  9. Rollag H, Evensen SA, Frøland SS, Glomstein A (1987)
    The significance of HIV antigen and HIV antibodies specific against envelope and core proteins in serum of HIV-infected hemophiliacs
    Eur J Haematol, 39 (4), 353-5
    DOI 10.1111/j.1600-0609.1987.tb00782.x, PubMed 3480236

Publications 1986

  1. Bruserud O, Degré M, Thorsby E (1986)
    Interleukin 2- and interferon-production and expression of interleukin 2 receptors by human mononuclear cells stimulated with mumps virus or phytohaemagglutinin
    Acta Pathol Microbiol Immunol Scand C, 94 (2), 51-5
    PubMed 3090859
  2. Bukholm G, Modalsli K, Degré M (1986)
    Effect of measles-virus infection and interferon treatment on invasiveness of Shigella flexneri in HEp2-cell cultures
    22 (4), 335-41
    DOI 10.1099/00222615-22-4-335, PubMed 3098977
  3. Degré M (1986)
    Interaction between viral and bacterial infections in the respiratory tract
    49, 140-5
    PubMed 2434989
  4. DEGRE M (1986)
    INTERACTION BETWEEN VIRAL AND BACTERIAL-INFECTIONS IN THE RESPIRATORY-TRACT
    Scand. J. Infect. Dis. (49), 140-145
  5. Degré M, Holberg-Petersen M (1986)
    Influence of a carcinogenic agent, 7.12 dimethylbenz (alpha) anthracene (DMBA), on production of interferon alpha/beta in murine and human cells
    Acta Pathol Microbiol Immunol Scand B, 94 (1), 51-5
    PubMed 3014815
  6. Jonassen TO, Grinde B (1986)
    Proteolytic response to nutritional step-down in Tetrahymena
    163 (1), 165-74
    DOI 10.1016/0014-4827(86)90569-0, PubMed 3510885
  7. Livden JK, Bjerke JR, Degre M, Matre R (1986)
    The effect of Goeckerman therapy on interferon in serum and suction blister fluid from patients with psoriasis
    114 (2), 217-25
    DOI 10.1111/j.1365-2133.1986.tb02800.x, PubMed 2418865
  8. Mustafa AS, Kvalheim G, Degre M, Godal T (1986)
    Mycobacterium bovis BCG-induced human T-cell clones from BCG-vaccinated healthy subjects: antigen specificity and lymphokine production
    53 (3), 491-7
    PubMed 2427449
  9. MUSTAFA AS, KVALHEIM G, DEGRE M, GODAL T (1986)
    MYCOBACTERIUM-BOVIS BCG-INDUCED HUMAN T-CELL CLONES FROM BCG-VACCINATED HEALTHY-SUBJECTS - ANTIGEN-SPECIFICITY AND LYMPHOKINE PRODUCTION
    Infect. Immun., 53 (3), 491-497
  10. Siebke JC, von der Lippe B, Hansson BG, Nordenfelt E, Degré M (1986)
    Prevalence and clinical effects of delta agent. Infections in Norwegian population subgroups
    18 (1), 33-6
    DOI 10.3109/00365548609032303, PubMed 3961420
  11. SIEBKE JC, VONDERLIPPE B, HANSSON BG, NORDENFELT E, DEGRE M (1986)
    PREVALENCE AND CLINICAL EFFECTS OF DELTA AGENT - INFECTIONS IN NORWEGIAN POPULATION SUBGROUPS
    Scand. J. Infect. Dis., 18 (1), 33-36
  12. von der Lippe E, Frøland S, Rollag H, Degre M (1986)
    Effect of fibroblast interferon and recombinant gamma interferon on zymosan-induced nitroblue tetrazolium reduction in mouse peritoneal macrophages
    Acta Pathol Microbiol Immunol Scand B, 94 (5), 343-6
    PubMed 3098042

Publications 1985

  1. BREDE HD, EHRENGUT W, PLOTKIN SA, SPIESS H, SCHILD G, GERSHON AA, DEGRE M, MENSER M, THIRY L, EGGERS HJ, SIMON C, PREBLUD SR, AMBROSCH F, MORRONDO RN, NICHOLSON K, BOUGHTON CR, DUDGEON JA, ENDERS G (1985)
    THE NEED FOR IMMUNIZATION AGAINST VARICELLA - GENERAL DISCUSSION
    Postgrad. Med. J., 61 4, 31-34
  2. Bukholm G, Degré M (1985)
    Effect of human gamma interferon on invasiveness of Salmonella typhimurium in HEp-2 cell cultures
    5 (1), 45-53
    PubMed 3921632
  3. BUKHOLM G, DEGRE M (1985)
    EFFECT OF HUMAN GAMMA INTERFERON ON INVASIVENESS OF SALMONELLA-TYPHIMURIUM IN HEP-2 CELL-CULTURES
    J. Interferon Res., 5 (1), 45-53
  4. Bukholm G, Holberg-Petersen M, Degré M (1985)
    Invasiveness of Salmonella typhimurium in HEp-2 cell cultures pretreated with UV-inactivated coxsackie virus
    Acta Pathol Microbiol Immunol Scand B, 93 (1), 61-5
    PubMed 2984878
  5. Hovig B, Rollag H, Dahl O (1985)
    Antibody to hepatitis B surface antigen among employees in the National Hospital, Oslo, Norway: a prevalence study
    122 (1), 127-34
    DOI 10.1093/oxfordjournals.aje.a114071, PubMed 4014189
  6. Kjeldsberg E, Rollag H, Lund H, Holberg-Pettersen M, Degré M (1985)
    Effect of gamma interferon on spreading of mouse peritoneal macrophages on solid surfaces
    Acta Pathol Microbiol Immunol Scand B, 93 (3), 165-70
    PubMed 3929557
  7. Qvigstad E, Onsrud M, Degré M, Skaug K (1985)
    Cell-mediated and humoral immune responses to chlamydial and herpesvirus antigens in patients with cervical carcinoma
    20 (2), 184-9
    DOI 10.1016/0090-8258(85)90140-4, PubMed 2982703
  8. SLORDAHL SH, WIGER D, STROMOY T, DEGRE M, THORSBY E, LIE SO (1985)
    VACCINATION OF CHILDREN WITH MALIGNANT DISEASE AGAINST VARICELLA
    Postgrad. Med. J., 61 4, 85-92
  9. Slørdahl SH, Wiger D, Strømøy T, Degre M, Thørsby E, Lie SO (1985)
    Vaccination of children with malignant disease against varicella
    61 Suppl 4, 85-92
    PubMed 3014484

Publications 1984

  1. BJERKE JR, DEGRE M, HAUKENES G, KROGH HK, LIVDEN JK, MATRE R (1984)
    T-CELLS, INTERFERONS AND RETROVIRUS-LIKE PARTICLES IN PSORIATIC LESIONS
    Acta Derm.-Venereol. (113), 29-33
  2. BJERKE JR, HAUKENES G, LIVDEN JK, MATRE R, DEGRE M (1984)
    ACID-LABILE ALPHA-INTERFERON
    N. Engl. J. Med., 310 (14), 922-923
  3. Bukholm G, Berdal BP, Haug C, Degré M (1984)
    Mouse fibroblast interferon modifies Salmonella typhimurium infection in infant mice
    45 (1), 62-6
    PubMed 6376362
  4. BUKHOLM G, BERDAL BP, HAUG C, DEGRE M (1984)
    MOUSE FIBROBLAST INTERFERON MODIFIES SALMONELLA-TYPHIMURIUM INFECTION IN INFANT MICE
    Infect. Immun., 45 (1), 62-66
  5. Bukholm G, Degré M (1984)
    Invasiveness of Salmonella typhimurium in HEp-2 cell cultures preinfected with Coxsackie B 1 virus
    Acta Pathol Microbiol Immunol Scand B, 92 (1), 45-51
    PubMed 6324532
  6. Degré M (1984)
    [Interferon--recent developments at basic and application levels]
    99 (3), 76-7, 71
    PubMed 6203095
  7. Degré M, Siebke JC, Frøland SS (1984)
    [Prevention of hepatitis B by vaccination]
    104 (27), 1906-7
    PubMed 6515608
  8. Rollag H, Degré M, Sonnenfeld G (1984)
    Effects of interferon-alpha/beta and interferon-gamma preparations on phagocytosis by mouse peritoneal macrophages
    20 (2), 149-55
    DOI 10.1111/j.1365-3083.1984.tb00988.x, PubMed 6236548
  9. Rollag H, Hovig T (1984)
    Phagocytosis of non-opsonized Escherichia coli by mouse peritoneal macrophages. An electron microscopic study
    Zentralbl Bakteriol Mikrobiol Hyg A, 257 (1), 93-107
    DOI 10.1016/S0174-3031(84)80047-5, PubMed 6380159
  10. Rollag H, Petersen G, Aars H, Siebke JC (1984)
    [Venereal diseases in homosexual men]
    104 (30), 2083-6
    PubMed 6548843
  11. Siebke JC, Degré M (1984)
    Prevalence of viral hepatitis in the staff in Norwegian anaesthesiology units
    28 (5), 549-53
    DOI 10.1111/j.1399-6576.1984.tb02117.x, PubMed 6496015
  12. Slørdahl SH, Lie SO, Wiger D, Winsnes R, Degre M, Strømøy T, Thorsby E (1984)
    [Vaccination of immunosuppressed children against varicella]
    104 (30), 2086-9
    PubMed 6095484
  13. Vinje O, Førre O, Degre M, Møller P (1984)
    Natural killer (NK) cell activity of peripheral blood lymphocytes from patients with Bechterew's syndrome (ankylosing spondylitis)
    13 (4), 297-302
    DOI 10.3109/03009748409111299, PubMed 6441246

Publications 1983

  1. BJERKE JR, HAUKENES G, LIVDEN JK, MATRE R, DEGRE M (1983)
    ACTIVATED LYMPHOCYTES-T, INTERFERON, AND RETROVIRUS-LIKE PARTICLES IN PSORIATIC LESIONS
    Arch. Dermatol., 119 (12), 955-956
  2. Bjerke JR, Haukenes G, Livden JK, Matre R, Degré M (1983)
    Activated T lymphocytes, interferon, and retrovirus-like particles in psoriatic lesions
    119 (12), 955-6
    PubMed 6197033
  3. Bjerke JR, Livden JK, Degré M, Matre R (1983)
    Interferon in suction blister fluid from psoriatic lesions
    108 (3), 295-9
    DOI 10.1111/j.1365-2133.1983.tb03967.x, PubMed 6187354
  4. Bukholm G, Degré M (1983)
    Effect of human leukocyte interferon on invasiveness of Salmonella species in HEp-2 cell cultures
    42 (3), 1198-202
    PubMed 6358041
  5. BUKHOLM G, DEGRE M (1983)
    EFFECT OF HUMAN-LEUKOCYTE INTERFERON ON INVASIVENESS OF SALMONELLA SPECIES IN HEP-2 CELL-CULTURES
    Infect. Immun., 42 (3), 1198-1202
  6. Degré M (1983)
    [Immunological defense factors against viral infections]
    103 (3), 177-8
    PubMed 6845309
  7. Degré M (1983)
    [Vaccines against cytomegalovirus infection]
    103 (3), 236-7
    PubMed 6302943
  8. Degré M, Belsnes K, Rollag H, Beck S, Sonnenfeld G (1983)
    Influence of the genotype of mice on the effect of interferon on phagocytic activity of macrophages
    173 (1), 27-31
    DOI 10.3181/00379727-173-41604, PubMed 6344094
  9. DEGRE M, BELSNES K, ROLLAG H, BECK S, SONNENFELD G (1983)
    INFLUENCE OF THE GENOTYPE OF MICE ON THE EFFECT OF INTERFERON ON PHAGOCYTIC-ACTIVITY OF MACROPHAGES
    Proc. Soc. Exp. Biol. Med., 173 (1), 27-31
  10. Degré M, Glasgow LA (1983)
    Establishment and preliminary characterization of a cell line persistently infected with Newcastle disease virus
    Acta Pathol Microbiol Immunol Scand B, 91 (6), 389-94
    PubMed 6324529
  11. DeGré M, Mellbye OJ, Clarke-Jenssen O (1983)
    Immune interferon in serum and synovial fluid in rheumatoid arthritis and related disorders
    42 (6), 672-6
    DOI 10.1136/ard.42.6.672, PubMed 6418086
  12. Ritland S, Blomhoff JP, Degre M (1983)
    [Hepatitis B virus--hepatocellular carcinoma]
    103 (33), 2237-9
    PubMed 6318382

Publications 1982

  1. DEGRE M (1982)
    BACTERIAL-MENINGITIS AFTER INFLUENZA
    Lancet, 1 (8275), 804
  2. Degré M, Rollag H (1982)
    Effect of murine beta-interferon preparation on phagocytosis and cyclic AMP levels in mouse peritoneal macrophages
    2 (2), 151-7
    PubMed 6288813
  3. DEGRE M, ROLLAG H (1982)
    EFFECT OF A MURINE BETA-INTERFERON PREPARATION ON PHAGOCYTOSIS AND CYCLIC-AMP LEVELS IN MOUSE PERITONEAL-MACROPHAGES
    J. Interferon Res., 2 (2), 151-157
  4. DEGRE M, ROLLAG H (1982)
    ON THE POSSIBLE ROLE OF INTERFERON IN INFECTIONS WITH NON-VIRAL AGENTS
    TEX REP BIOL MED, 41, 388-394
  5. Degré M, Rollag H, Kjeldsberg E (1982)
    Morphological parameters of the effect of interferon on mouse peritoneal macrophages
    299 (1094), 131-3
    DOI 10.1098/rstb.1982.0115, PubMed 6128749
  6. Dobloug JH, Førre O, Kvien TK, Egeland T, Degré M (1982)
    Natural killer (NK) cell activity of peripheral blood, synovial fluid, and synovial tissue lymphocytes from patients with rheumatoid arthritis and juvenile rheumatoid arthritis
    41 (5), 490-4
    DOI 10.1136/ard.41.5.490, PubMed 6181746
  7. Lingaas E, Degré M (1982)
    [Screening for rubella antibodies in newly employed women at the National Hospital]
    102 (25), 1272-3
    PubMed 7164071
  8. Melby K, Midtvedt T, Degré M (1982)
    Effect of human leukocyte interferon on phagocytic activity of polymorphonuclear leukocytes
    Acta Pathol Microbiol Immunol Scand B, 90 (3), 181-4
    PubMed 6181651
  9. Rollag H, Degré M (1982)
    Effect of beta-interferon on in vitro spreading of mouse peritoneal macrophages
    Acta Pathol Microbiol Immunol Scand B, 90 (6), 389-95
    PubMed 7168315
  10. Rollag H, Mørland B, Degré M (1982)
    Effect of a homologous beta-interferon preparation on degradation of Escherichia coli and on lysosomal enzyme activities in mouse peritoneal macrophages
    Acta Pathol Microbiol Immunol Scand B, 90 (2), 113-8
    PubMed 6177190
  11. Siebke JC, Degré M, Ritland S, Enger SC (1982)
    Prevalence of hepatitis A antibodies in a normal population and some selected groups of patients in Norway
    115 (2), 185-91
    DOI 10.1093/oxfordjournals.aje.a113290, PubMed 7058777

Publications 1981

  1. Degre M, Glasgow LA (1981)
    Effect of interferon on cyclic adenosine monophosphate levels in cells
    Antiviral Res, 1 (3), 185-92
    DOI 10.1016/0166-3542(81)90007-3, PubMed 6175278
  2. Degré M, Rollag H (1981)
    On the possible role of interferon in infections with non-viral agents
    41, 388-94
    PubMed 6184830
  3. DEGRE M, SONNENFELD G, ROLLAG H, MORLAND B (1981)
    EFFECT OF GAMMA INTERFERON PREPARATIONS ON INVITRO PHAGOCYTOSIS AND DEGRADATION OF ESCHERICHIA-COLI BY MOUSE PERITONEAL-MACROPHAGES
    J. Interferon Res., 1 (4), 505-512
  4. Degré M, Sonnenfeld G, Rollag H, Mørland B (1981)
    Effect of gamma interferon preparations on in vitro phagocytosis and degradation of Escherichia coli by mouse peritoneal macrophages
    1 (4), 505-12
    PubMed 6180084
  5. Egge K, Djupesland G, Modalsli B, Degré M (1981)
    Severe hearing loss and retinopathy in children: on the possible association with rubella virus infection
    10 (2), 75-9
    PubMed 7280544
  6. EGGE K, DJUPESLAND G, MODALSLI B, DEGRE M (1981)
    SEVERE HEARING-LOSS AND RETINOPATHY IN CHILDREN - ON THE POSSIBLE ASSOCIATION WITH RUBELLA-VIRUS INFECTION
    Scand. Audiol., 10 (2), 75-79
  7. Olstad R, Degré M, Seljelid R (1981)
    Production of immune interferon (type II) in cocultures of mouse peritoneal macrophages and syngeneic tumour cells
    13 (6), 605-8
    DOI 10.1111/j.1365-3083.1981.tb00175.x, PubMed 6171873
  8. Rollag H, Degré M (1981)
    Effect of interferon preparations on the uptake of non-opsonized Escherichia coli by mouse peritoneal macrophages
    89 (3), 153-9
    PubMed 6171991
  9. ROLLAG H, DEGRE M (1981)
    EFFECT OF INTERFERON PREPARATIONS ON THE UPTAKE OF NON-OPSONIZED ESCHERICHIA-COLI BY MOUSE PERITONEAL-MACROPHAGES
    ACTA PATH MICRO IM B, 89 (3), 153-159

Publications 1980

  1. Degré M (1980)
    Antiviral and cell multiplication inhibitory activities of mouse interferon poreparations tested on an interferon sensitive murine sarcoma cell line
    88 (4), 219-23
    PubMed 6158254
  2. Degré M (1980)
    Adsorption of interferon to homologous and heterologous cells. Brief report
    65 (1), 71-6
    DOI 10.1007/bf01340543, PubMed 6158931
  3. DEGRE M (1980)
    ANTI-VIRAL AND CELL MULTIPLICATION INHIBITORY ACTIVITIES OF MOUSE INTERFERON PREPARATIONS TESTED ON AN INTERFERON SENSITIVE MURINE SARCOMA CELL-LINE
    ACTA PATH MICRO IM B, 88 (4), 219-223
  4. Degré M, Rollag H (1980)
    Pathogenesis of Sendasi virus infection in mice. On the possible role of interferon on the development of disease
    88 (3), 177-81
    PubMed 6160724
  5. DEGRE M, ROLLAG H (1980)
    PATHOGENESIS OF SENDAI VIRUS-INFECTION IN MICE - ON THE POSSIBLE ROLE OF INTERFERON ON THE DEVELOPMENT OF DISEASE
    ACTA PATH MICRO IM B, 88 (3), 177-181
  6. Melby K, Rollag H (1980)
    [Amidinopenicillins (mecillinam and pivmecillinam). A new group of beta-lactamate antibiotics]
    100 (2), 105-6
    PubMed 6246655
  7. Rollag H (1980)
    Degradation of non-opsonized 32P-labelled E. coli by unstimulated mouse peritoneal macrophages. Evaluation of a method
    88 (3), 109-14
    PubMed 7004082
  8. ROLLAG H (1980)
    DEGRADATION OF NON-OPSONIZED P-32-LABELED ESCHERICHIA-COLI BY UNSTIMULATED MOUSE PERITONEAL-MACROPHAGES - EVALUATION OF A METHOD
    ACTA PATH MICRO IM C, 88 (3), 109-114

Publications 1979

  1. Degré M, Rollag H (1979)
    Rubella screening by hemolysis-in-gel-test
    2 (8143), 644-5
    PubMed 90314
  2. Degré M, Rollag H (1979)
    Screening for rubella antibodies by a single radial haemolysis test
    2 (2), 25-30
    PubMed 398458
  3. DEGRE M, ROLLAG H (1979)
    INFLUENCE OF INTERFERON ON THE INVIVO PHAGOCYTIC-ACTIVITY OF RETICULOENDOTHELIAL SYSTEM CELLS
    J RETICULOENDOTH SOC, 25 (5), 489-493
  4. Degré M, Rollag H (1979)
    Influence of interferon on the in vivo phagocytic activity of reticuloendothelial system cells
    25 (5), 489-93
    PubMed 458780
  5. DEGRE M, ROLLAG H (1979)
    RUBELLA SCREENING BY HEMOLYSIS-IN-GEL TEST
    Lancet, 2 (8143), 644-645
  6. Djupesland G, Flottorp G, Degré M, Stien R, Skrede S (1979)
    Cochlear hearing loss and viral infection
    87 (3-4), 247-54
    DOI 10.3109/00016487909126416, PubMed 375666
  7. Rollag H (1979)
    Uptake of non-opsonized E. coli by unstimulated mouse peritoneal macrophages
    87C (2), 99-105
    PubMed 375677
  8. ROLLAG H (1979)
    UPTAKE OF NON-OPSONIZED ESCHERICHIA-COLI BY UNSTIMULATED MOUSE PERITONEAL-MACROPHAGES
    ACTA PATH MICRO IM C, 87 (2), 99-105
  9. Rollag H, Midtvedt T, Hovig B, Dahl O (1979)
    Sensitivity patterns of bacteria and antibiotic usage at the National Hospital of Norway in 1976 and 1978
    244 (4), 515-24
    PubMed 543352
  10. ROLLAG H, MIDTVEDT T, HOVIG B, DAHL O (1979)
    SENSITIVITY PATTERNS OF BACTERIA AND ANTIBIOTIC USAGE AT THE NATIONAL-HOSPITAL-OF-NORWAY IN 1976 AND 1978
    ZBL BAKT-INT J MED M, 244 (4), 515-524

Publications 1978

  1. Degré M (1978)
    Cholera toxin inhibits antiviral and growth inhibitory activities of human interferon
    157 (2), 253-5
    PubMed 202975
  2. DEGRE M (1978)
    CHOLERA TOXIN INHIBITS ANTI-VIRAL AND GROWTH INHIBITORY ACTIVITIES OF HUMAN INTERFERON
    Proc. Soc. Exp. Biol. Med., 157 (2), 253-255
  3. Degré M (1978)
    Effect of human leukocyte interferon on the permeability of the cytoplasma membrane of cultured cells
    86B (5), 303-7
    PubMed 716922
  4. DEGRE M (1978)
    EFFECT OF HUMAN LEUKOCYTE INTERFERON ON PERMEABILITY OF CYTOPLASMA MEMBRANE OF CULTURED-CELLS
    ACTA PATH MICRO IM B, 86 (5), 303-307
  5. Degré M, Bukholm G, Lund EE, Djupesland G (1978)
    Attempts to isolate virus from human trigeminal and facial ganglions
    166 (1-4), 151-6
    PubMed 214678
  6. DEGRE M, BUKHOLM G, LUND EE, DJUPESLAND G (1978)
    ATTEMPTS TO ISOLATE VIRUS FROM HUMAN TRIGEMINAL AND FACIAL GANGLIONS
    Med. Microbiol. Immunol., 166 (1-4), 151-156
  7. Degré M, Wilhelmsen KW (1978)
    [Interferons. Biological principal and practical application]
    98 (24), 1152-4
    PubMed 684722
  8. Rollag H, Midtvedt T (1978)
    Comparative antibiotic sensitivity testing of bacteria with a paper disc and a tablet method
    24 (5), 297-300
    DOI 10.1159/000237796, PubMed 668447

Publications 1977

  1. Degré M, Gláz ET (1977)
    Interferon induction in human cell cultures by small molecular inducers (tilorone and acridines)
    85 (3), 189-94
    PubMed 888701
  2. DEGRE M, GLAZ ET (1977)
    INTERFERON INDUCTION IN HUMAN CELL-CULTURES BY SMALL MOLECULAR INDUCERS (TILORONE AND ACRIDINES)
    ACTA PATH MICRO IM B, 85 (3), 189-194
  3. Degré M, Hovig B, Midtvedt T (1977)
    [Can the transport agar method be used for determination of resistance in urinary tract infections?]
    97 (5), 248-50
    PubMed 841561
  4. DJUPESLAND G, DEGRE M, STIEN R, SKREDE S (1977)
    ACUTE PERIPHERAL FACIAL PALSY - PART OF A CRANIAL POLYNEUROPATHY
    Arch. Otolaryngol. Head Neck Surg., 103 (11), 641-644
  5. Djupesland G, Degré M, Stien R, Skrede S (1977)
    Acute peripheral facial palsy. Part of a cranial polyneuropathy?
    103 (11), 641-4
    DOI 10.1001/archotol.1977.00780280041004, PubMed 200210
  6. Rollag H, Hagen R (1977)
    [Antibacterial treatment of septic arthritis]
    97 (3), 151-2
    PubMed 835121
  7. Rollag H, Holter O (1977)
    [Acute cholecystitis]
    97 (7), 361-2
    PubMed 847697
  8. Rollag H, Melby K (1977)
    [Ampicillin--pivampicillin--amoxicillin]
    97 (33), 1759-60
    PubMed 244370

Publications 1976

  1. Dahl H, Degré M (1976)
    Human interferon and cell growth inhibition. I. Inhibitory effect of human interferon on the growth rate of cultured human cells
    84B (5), 285-92
    PubMed 184682
  2. DAHL H, DEGRE M (1976)
    EFFECT OF ASCORBIC-ACID ON PRODUCTION OF HUMAN INTERFERON AND ANTIVIRAL ACTIVITY INVITRO
    ACTA PATH MICRO IM B, 84 (5), 280-284
  3. Dahl H, Degré M (1976)
    The effect of ascorbic acid on production of human interferon and the antiviral activity in vitro
    84B (5), 280-4
    PubMed 970135
  4. DAHL H, DEGRE M (1976)
    HUMAN INTERFERON AND CELL-GROWTH INHIBITION .1. INHIBITORY EFFECT OF HUMAN INTERFERON ON GROWTH-RATE OF CULTURED HUMAN CELLS
    ACTA PATH MICRO IM B, 84 (5), 285-292
  5. Degré M, Dahl H, Vandvik B (1976)
    Interferon in the serum and cerebrospinal fluid in patients with multiple sclerosis and other neurological disorders
    53 (2), 152-60
    DOI 10.1111/j.1600-0404.1976.tb04333.x, PubMed 1266564
  6. DEGRE M, HOVIG T (1976)
    FUNCTIONAL AND ULTRASTRUCTURAL STUDIES OF EFFECTS OF HUMAN INTERFERON ON CELL-MEMBRANES OF INVITRO CULTURED-CELLS
    ACTA PATH MICRO IM B, 84 (6), 347-358
  7. Degré M, Hovig T (1976)
    Functional and ultrastructural studies of the effects of human interferon on cell membranes of in vitro cultured cells
    84B (6), 347-58
    PubMed 187008
  8. Degre M, Vandvik B (1976)
    [Nobel prizes 1976 in physiology and medicine]
    92 (33), 1754-5
    PubMed 996844
  9. Djupesland G, Berdal P, Johannessen TA, Degré M, Stien R, Skrede S (1976)
    Viral infection as a cause of acute peripheral facial palsy
    102 (7), 403-6
    DOI 10.1001/archotol.1976.00780120051005, PubMed 938319
  10. DJUPESLAND G, BERDAL P, JOHANNESSEN TA, DEGRE M, STIEN R, SKREDE S (1976)
    VIRAL-INFECTION AS A CAUSE OF ACUTE PERIPHERAL FACIAL PALSY
    Arch. Otolaryngol. Head Neck Surg., 102 (7), 403-406
  11. MIDTVEDT T, TVETE E, HOVIG B, ROLLAG H (1976)
    COMPUTER SYSTEM FOR HANDLING DATA FROM BACTERIAL SENSITIVITY TESTING
    COMPUT PROG BIOMED, 6 (3), 178-186
  12. Midtvedt T, Tvete E, Hovig B, Rollag H (1976)
    A computer system for handling data from bacterial sensitivity testing
    6 (3), 178-86
    PubMed 1000977
  13. ROLLAG H, DEGRE M (1976)
    EFFECT OF ANTIBIOTICS ON INTERFERON-PRODUCTION IN MICE
    ACTA PATH MICRO IM B, 84 (6), 369-372
  14. Rollag H, degré M (1976)
    Effect of antibiotics on interferon production in mice
    84B (6), 369-72
    PubMed 998256
  15. Sodal G, Kvambe V, Rollag H, Fauchald P, Flatmark A (1976)
    [Listeria meningitis in adults]
    96 (23), 1198-9
    PubMed 968840
  16. Vandvik B, Norrby E, Nordal HJ, Degré M (1976)
    Oligoclonal measles virus-specific IgG antibodies isolated from cerebrospinal fluids, brain extracts, and sera from patients with subacute sclerosing panencephalitis and multiple sclerosis
    5 (8), 979-92
    DOI 10.1111/j.1365-3083.1976.tb03050.x, PubMed 996452

Publications 1975

  1. Berdal BP, Bergan T, Midtvedt T, Rollag H, Wetterhus S (1975)
    [Penicillin V]
    95 (31), 1795-6
    PubMed 810918
  2. Dahl H, Degre M (1975)
    Separation of antiviral activity of human interferon from cell growth inhibitory effect
    257 (5529), 799-800
    DOI 10.1038/257799a0, PubMed 1186865
  3. DEGRE M, ELGJO K (1975)
    INFLUENCE OF SYNTHETIC POLYNUCLEOTIDES AND INTERFERON ON INVITRO GROWTH OF CELLS DERIVED FROM A MOUSE SARCOMA
    ACTA PATH MICRO IM A, 1974 248, 61-68
  4. Djupesland G, Berdal P, Johannessen TA, Degré M, Stien R, Skrede S (1975)
    The role of viral infection in acute peripheral facial palsy
    79 (3-4), 221-7
    DOI 10.3109/00016487509124677, PubMed 1136761
  5. Elgjo K, Degré M (1975)
    Polyinosinic-polycytidylic acid: inhibition of cell proliferation in carcinogen-treated epidermis and in carcinogen-induced skin tumors in mice
    54 (1), 219-21
    DOI 10.1093/jnci/54.1.219, PubMed 1113302
  6. Otterstad JE, Rollag H, Hagen AG (1975)
    [Retroperitoneal, mediastinal and subcutaneous emphysema and bacillary dysentery]
    95 (6), 359-61
    PubMed 1092028
  7. Rollag H, Berdal BP, Bergan T, Degré M, Hovig B, Midtvedt T (1975)
    [Letter: Microstix and N-labstix "Ames"--unsafe for proving bacteriuria]
    95 (3), 198
    PubMed 1118846
  8. Rollag H, Midtvedt T, Wetterhus S (1975)
    Serum levels of penicillin v after oral administration of pediatric preparations to healthy subjects
    64 (3), 421-4
    DOI 10.1111/j.1651-2227.1975.tb03858.x, PubMed 808089
  9. ROLLAG H, MIDTVEDT T, WETTERHUS S (1975)
    SERUM LEVELS OF PENICILLIN-V AFTER ORAL-ADMINISTRATION OF PEDIATRIC PREPARATIONS TO HEALTHY SUBJECTS
    ACTA PAEDIATR SCAND, 64 (3), 421-424
  10. Vandvik B, Degré M (1975)
    Measles virus antibodies in serum and cerebrospinal fluid in patients with multiple sclerosis and other neurological disorders, with special reference to measles antibody synthesis within the central nervous system
    24 (2), 201-19
    DOI 10.1016/0022-510x(75)90233-6, PubMed 1113135

Publications 1974

  1. Degré M (1974)
    Influence of exogenous interferon on the peripheral white blood cell count in mice
    14 (6), 699-703
    DOI 10.1002/ijc.2910140602, PubMed 4463167
  2. Degré M (1974)
    [Virus as a cause of leukemia and blood cell disease in man]
    94 (32), 2205-7
    PubMed 4140582
  3. Degré M, Dahl H (1974)
    Interferon production and prevention of viral infections in mice by components of a mixed bacterial vaccine
    82 (6), 904-10
    PubMed 4549161
  4. DEGRE M, DAHL H (1974)
    INTERFERON-PRODUCTION AND PREVENTION OF VIRAL-INFECTIONS IN MICE BY COMPONENTS OF A MIXED BACTERIAL VACCINE
    ACTA PATH MICRO IM B, B 82 (6), 904-910
  5. Degré M, Elgjo K (1974)
    Influence of synthetic polynucleotides and interferon on in vitro growth of cells derived from a mouse sarcoma
    Suppl 248, 61-8
    PubMed 4217556

Publications 1973

  1. Degré M (1973)
    Influence of polyinosinic: polycytidylic acid on the circulating white blood cells in mice
    142 (4), 1087-91
    PubMed 4694806
  2. DEGRE M (1973)
    INFLUENCE OF POLYINOSINIC-POLYCYTIDYLIC ACID ON CIRCULATING WHITE BLOOD-CELLS IN MICE
    Proc. Soc. Exp. Biol. Med., 142 (4), 1087-1091
  3. Degré M (1973)
    [Acute effects of cigarette smoke on the respiratory tract]
    93 (6), 362-5
    PubMed 4572673
  4. DEGRE M, DAHL H (1973)
    ENHANCED EFFECT OF REPEATED ADMINISTRATION OF BACTERIAL VACCINE AGAINST VIRAL RESPIRATORY-INFECTION
    Infect. Immun., 7 (5), 771-776
  5. Degré M, Dahl H (1973)
    Enhanced effect of repeated administration of bacterial vaccine against viral respiratory infection
    7 (5), 771-6
    PubMed 4357990
  6. DEGRE M, MIDTVEDT T (1973)
    EFFECT OF STANDARD BACTERIAL VACCINE ON INFLUENZA-VIRUS INFECTION AND INTERFERON-PRODUCTION IN GERMFREE MICE
    ACTA PATH MICRO IM B, B 81 (6), 782-786
  7. Degré M, Midtvedt T (1973)
    Effect of standard bacterial vaccine on influenza virus infection and interferon production in germfree mice
    81 (6), 782-6
    PubMed 4521974
  8. ELGIO K, DEGRE M (1973)
    POLYINOSINIC-POLYCYTIDYLIC ACID IN 2-STAGE SKIN CARCINOGENESIS - EFFECT ON EPIDERMAL GROWTH PARAMETERS AND INTERFERON INDUCTION IN TREATED MICE
    J. Natl. Cancer Inst., 51 (1), 171-177
  9. Vandvik B, Froland SS, Hoyeraal HM, Stien R, Degré M (1973)
    Immunological features in a case of subacute sclerosing panencephalitis treated with transfer factor
    2 (4), 367-74
    DOI 10.1111/j.1365-3083.1973.tb02045.x, PubMed 4797728

Publications 1972

  1. Dahl H, Degré M (1972)
    A micro assay for mouse and human interferon
    80 (6), 863-70
    PubMed 4345661
  2. Dahl H, Degré M (1972)
    Preventive effect of a nonviral interferon inducer, a bacterial vaccine, on experimental influenza in mice
    80 (3), 467-74
    PubMed 4505773
  3. DAHL H, DEGRE M (1972)
    MICRO ASSAY FOR MOUSE AND HUMAN INTERFERON
    ACTA PATH MICRO IM B, B 80 (6), 863-870
  4. Degre M (1972)
    [Slow virus infections]
    92 (11), 783-5
    PubMed 5063782
  5. Degré M (1972)
    Effect of a standard bacterial vaccine on infection with an obligate intracellular parasite (Toxoplasma gondii) in mice
    80 (3), 478-80
    PubMed 4505774
  6. Degré M (1972)
    [Possible interaction between viral and bacterial agents in respiratory tract infections]
    92 (8), 556-8
    PubMed 5021893
  7. Degré M, Vandvik B, Hovig T (1972)
    Subacute sclerosing panencephalitis: isolation and ultrastructural characterization of a measles-like virus from brain obtained at autopsy
    80 (5), 713-28
    PubMed 4629361

Publications 1971

  1. Degré M (1971)
    Synergistic effect in viral-bacterial infection. 5. Functional studies on the role of the ciliary activity in the mouse trachea
    79 (2), 137-41
    PubMed 4325914
  2. Degré M (1971)
    Synergistic effect in viral-bacterial infection. 4. The leukocyte response to parainfluenza virus infection in the respiratory tract of mice, and the influence of antibiotics on the development of infection
    79 (1), 88-94
    PubMed 4324936
  3. Degre M, Dahl H (1971)
    Production of an interferon-like agent following inoculation with bacterial vaccine
    137 (1), 233-6
    DOI 10.3181/00379727-137-35551, PubMed 4325773
  4. Degré M, Elgjo K (1971)
    Methylcholanthrene-induced skin carcinogenesis modified by treatment with polyinosinic:polycytidylic acid (poly I:C)
    79 (6), 687-8
    PubMed 5123526
  5. Degré M, Midtvedt T (1971)
    Respiratory infection with parainfluenza 1, Sendai virus in gnotobiotic and conventional mice
    79 (1), 123-4
    PubMed 4324935
  6. Degré M, Solberg LA (1971)
    Synergistic effect in viral-bacterial infection. 3. Histopathological changes in the trachea of mice following viral and bacterial infection
    79 (2), 129-36
    PubMed 4325913

Publications 1970

  1. Degré M (1970)
    [Quantitative and semiquantitative methods for the diagnosis of bacteriuria]
    90 (1), 27-30
    PubMed 5426183
  2. Degré M (1970)
    Synergistic effect in viral-bacterial infection. 2. Influence of viral infection on the phagocytic ability of alveolar macrophages
    78 (1), 41-50
    PubMed 4316170
  3. Skjorten F, Kierulf PB, Degré M (1970)
    Formation of hyaline microthrombi in the mouse. Evidence for dependence on the fibrinolytic system
    78 (3), 351-61
    PubMed 5507260

Publications 1969

  1. Degré M (1969)
    Phagocytic and bactericidal activities of peritoneal and alveolar macrophages from mice
    2 (3), 353-7
    DOI 10.1099/00222615-2-3-353, PubMed 5314333

Publications 1968

  1. Degré M (1968)
    [Etiological disgnosis of purulent meningitis]
    88 (12), 1091-4
    PubMed 4387023
  2. Degré M, Glasgow LA (1968)
    Synergistic effect in viral-bacterial infection. I. Combined infection of the respiratory tract in mice with parainfluenza virus and Hemophilus influenza
    118 (5), 449-62
    DOI 10.1093/infdis/118.5.449, PubMed 4302684

Publications 1967

  1. Degré M (1967)
    Reproducibility of staphylococcal bacteriophage types by use of different concentrations of bacteriophage
    15 (4), 907-11
    PubMed 4227800

Publications 1966

  1. Degré M (1966)
    Bacteriophage typing of Staphylococcus aureus using a single concentration of phage (100 x RTD)
    66 (1), 105-12
    DOI 10.1111/apm.1966.66.1.105, PubMed 4224085
  2. Degré M (1966)
    Simple quantitative methods in the bacteriological diagnosis of urinary tract infection
    16 (8), 184-96
    PubMed 5329982

Publications 1965

  1. Degrè M, Ulstrup JC (1965)
    [Bacteriological studies on otitis media. 1-year case material]
    85 (12), 994-7
    PubMed 5864803
  2. Daae L, Degré M (1965)
    [Bacteriological studies of urine. A comparison between washed down specimens and catheterized specimens from bedridden women]
    85 (12), 1003-5
    PubMed 5865811

Publications 1964

  1. DEGRE M (1964)
    [DISINFECTION OF THE DUMMY FIGURES USED IN TRAINING FOR MOUTH-TO-MOUTH RESPIRATION METHODS]
    84, 1112-4
    PubMed 14230470

Publications 1962

  1. DEGRE M (1962)
    [Anaphylactic reaction to carisoprodol]
    82, 1589
    PubMed 14026463

Publications 1957

  1. TIGYI A, LISSAK K, DEGRE M, PETER K (1957)
    [Role of neurohormonal factors in pathological changes in lungs]
    8 (1-2), 86-9
    PubMed 13450585
 
Page visits: 1312